Guido Kroemer - Publications

Affiliations: 
Compiègne 
Area:
Acute myeloid leukemia, PZP, ER stress, Videomicroscopy, MPS1, LAMP1, Calreticulin (CRT, CXCL8, Chemoprevention, Erlotinib

500 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Petrazzuolo A, Le Naour J, Vacchelli E, Gaussem P, Ellouze S, Jourdi G, Solary E, Fontenay M, Smadja DM, Kroemer G. No impact of cancer and plague-relevant polymorphisms on COVID-19. Oncoimmunology. 9: 1857112. PMID 33344044 DOI: 10.1080/2162402X.2020.1857112  0.92
2020 Petroni G, Buqué A, Zitvogel L, Kroemer G, Galluzzi L. Immunomodulation by targeted anticancer agents. Cancer Cell. PMID 33338426 DOI: 10.1016/j.ccell.2020.11.009  1
2020 Yamazaki T, Pedro JMB, Galluzzi L, Kroemer G, Pietrocola F. Autophagy in the cancer-immunity dialogue. Advanced Drug Delivery Reviews. PMID 33301821 DOI: 10.1016/j.addr.2020.12.003  1
2020 Castoldi F, Humeau J, Martins I, Lachkar S, Loew D, Dingli F, Durand S, Enot D, Bossut N, Chery A, Aprahamian F, Demont Y, Opolon P, Signolle N, Sauvat A, ... ... Kroemer G, et al. Autophagy-mediated metabolic effects of aspirin. Cell Death Discovery. 6: 129. PMID 33298861 DOI: 10.1038/s41420-020-00365-0  1
2020 Fucikova J, Kepp O, Kasikova L, Petroni G, Yamazaki T, Liu P, Zhao L, Spisek R, Kroemer G, Galluzzi L. Detection of immunogenic cell death and its relevance for cancer therapy. Cell Death & Disease. 11: 1013. PMID 33243969 DOI: 10.1038/s41419-020-03221-2  1
2020 Le Naour J, Liu P, Zhao L, Adjemian S, Sztupinszki Z, Taieb J, Mulot C, Silvin A, Dutertre CA, Ginhoux F, Sauvat A, Cerrato G, Castoldi F, Martins I, Stoll G, ... ... Kroemer G, et al. A TLR3 ligand reestablishes chemotherapeutic responses in the context of FPR1 deficiency. Cancer Discovery. PMID 33046534 DOI: 10.1158/2159-8290.CD-20-0465  0.96
2020 Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Kroemer G, et al. Publisher Correction: Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 4787. PMID 32943636 DOI: 10.1038/s41467-020-18719-8  1
2020 Song X, Zhou Z, Li H, Xue Y, Lu X, Bahar I, Kepp O, Hung MC, Kroemer G, Wan Y. Pharmacological suppression of B7-H4 glycosylation restores antitumor immunity in immune-cold breast cancers. Cancer Discovery. PMID 32938586 DOI: 10.1158/2159-8290.CD-20-0402  0.96
2020 Frega G, Wu Q, Le Naour J, Vacchelli E, Galluzzi L, Kroemer G, Kepp O. Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. Oncoimmunology. 9: 1796002. PMID 32934889 DOI: 10.1080/2162402X.2020.1796002  1
2020 Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 9: 1777625. PMID 32934882 DOI: 10.1080/2162402X.2020.1777625  1
2020 Liu P, Zhao L, Ferrere G, Alves-Costa-Silva C, Ly P, Wu Q, Tian AL, Derosa L, Zitvogel L, Kepp O, Kroemer G. Combination treatments with hydroxychloroquine and azithromycin are compatible with the therapeutic induction of anticancer immune responses. Oncoimmunology. 9: 1789284. PMID 32923151 DOI: 10.1080/2162402X.2020.1789284  0.96
2020 Yakhine-Diop SMS, Morales-García JA, Niso-Santano M, González-Polo RA, Uribe-Carretero E, Martinez-Chacon G, Durand S, Maiuri MC, Aiastui A, Zulaica M, Ruíz-Martínez J, López de Munain A, Pérez-Tur J, Pérez-Castillo A, Kroemer G, et al. Metabolic alterations in plasma from patients with familial and idiopathic Parkinson's disease. Aging. 12. PMID 32903216 DOI: 10.18632/aging.103992  0.96
2020 Fluckiger A, Daillère R, Sassi M, Sixt BS, Liu P, Loos F, Richard C, Rabu C, Alou MT, Goubet AG, Lemaitre F, Ferrere G, Derosa L, Duong CPM, Messaoudene M, ... ... Kroemer G, et al. Cross-reactivity between tumor MHC class I-restricted antigens and an enterococcal bacteriophage. Science (New York, N.Y.). 369: 936-942. PMID 32820119 DOI: 10.1126/science.aax0701  0.88
2020 Huang J, Chen P, Liu K, Liu J, Zhou B, Wu R, Peng Q, Liu ZX, Li C, Kroemer G, Lotze M, Zeh H, Kang R, Tang D. CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer. Gut. PMID 32816920 DOI: 10.1136/gutjnl-2019-320441  0.64
2020 Sauvat A, Ciccosanti F, Colavita F, Di Rienzo M, Castilletti C, Capobianchi MR, Kepp O, Zitvogel L, Fimia GM, Piacentini M, Kroemer G. On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2. Cell Death & Disease. 11: 656. PMID 32814759 DOI: 10.1038/s41419-020-02842-x  0.96
2020 Pol JG, Atherton MJ, Stephenson KB, Bridle BW, Workenhe ST, Kazdhan N, McGray AR, Wan Y, Kroemer G, Lichty BD. Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning. Journal For Immunotherapy of Cancer. 8. PMID 32792361 DOI: 10.1136/jitc-2020-000981  0.72
2020 Galluzzi L, Humeau J, Buqué A, Zitvogel L, Kroemer G. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors. Nature Reviews. Clinical Oncology. PMID 32760014 DOI: 10.1038/s41571-020-0413-z  1
2020 Fucikova J, Spisek R, Kroemer G, Galluzzi L. Calreticulin and cancer. Cell Research. PMID 32733014 DOI: 10.1038/s41422-020-0383-9  1
2020 Buqué A, Bloy N, Perez-Lanzón M, Iribarren K, Humeau J, Pol JG, Levesque S, Mondragon L, Yamazaki T, Sato A, Aranda F, Durand S, Boissonnas A, Fucikova J, Senovilla L, ... ... Kroemer G, et al. Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer. Nature Communications. 11: 3819. PMID 32732875 DOI: 10.1038/s41467-020-17644-0  1
2020 Pietrocola F, Castoldi F, Zischka H, Kroemer G. Extending the mode of action of triethylenetetramine (trientine): Autophagy besides copper chelation. Journal of Hepatology. PMID 32684364 DOI: 10.1016/j.jhep.2020.05.046  0.96
2020 Madeo F, Hofer SJ, Pendl T, Bauer MA, Eisenberg T, Carmona-Gutierrez D, Kroemer G. Nutritional Aspects of Spermidine. Annual Review of Nutrition. PMID 32634331 DOI: 10.1146/annurev-nutr-120419-015419  0.88
2020 Joseph A, Moriceau S, Sica V, Anagnostopoulos G, Pol J, Martins I, Lafarge A, Maiuri MC, Leboyer M, Loftus J, Bellivier F, Belzeaux R, Berna F, Etain B, Capdevielle D, ... ... Kroemer G, et al. Metabolic and psychiatric effects of acyl coenzyme A binding protein (ACBP)/diazepam binding inhibitor (DBI). Cell Death & Disease. 11: 502. PMID 32632162 DOI: 10.1038/s41419-020-2716-5  1
2020 Beauvarlet J, Nath Das R, Alvarez-Valadez K, Martins I, Muller A, Darbo E, Richard E, Soubeyran P, Kroemer G, Guillon J, Mergny JL, Djavaheri-Mergny M. Triarylpyridine Compounds and Chloroquine Act in Concert to Trigger Lysosomal Membrane Permeabilization and Cell Death in Cancer Cells. Cancers. 12. PMID 32570977 DOI: 10.3390/cancers12061621  0.92
2020 Pietrocola F, Castoldi F, Madeo F, Kroemer G. Triethylenetetramine (trientine): a caloric restriction mimetic with a new mode of action. Autophagy. 1-3. PMID 32544364 DOI: 10.1080/15548627.2020.1778293  0.96
2020 Allouch A, Di Primio C, Paoletti A, Lê-Bury G, Subra F, Quercioli V, Nardacci R, David A, Saïdi H, Cereseto A, Ojcius DM, Montagnac G, Niedergang F, Pancino G, Saez-Cirion A, ... ... Kroemer G, et al. SUGT1 controls susceptibility to HIV-1 infection by stabilizing microtubule plus-ends. Cell Death and Differentiation. PMID 32514048 DOI: 10.1038/s41418-020-0573-5  0.76
2020 Roberti MP, Yonekura S, Duong CPM, Picard M, Ferrere G, Tidjani Alou M, Rauber C, Iebba V, Lehmann CHK, Amon L, Dudziak D, Derosa L, Routy B, Flament C, Richard C, ... ... Kroemer G, et al. Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancer. Nature Medicine. PMID 32451498 DOI: 10.1038/s41591-020-0882-8  0.88
2020 Zischka H, Kroemer G. Copper - a novel stimulator of autophagy. Cell Stress. 4: 92-94. PMID 32420529 DOI: 10.15698/cst2020.05.218  0.44
2020 Dufey E, Bravo-San Pedro JM, Eggers C, González-Quiroz M, Urra H, Sagredo AI, Sepulveda D, Pihán P, Carreras-Sureda A, Hazari Y, Sagredo EA, Gutierrez D, Valls C, Papaioannou A, Acosta-Alvear D, ... ... Kroemer G, et al. Genotoxic stress triggers the activation of IRE1α-dependent RNA decay to modulate the DNA damage response. Nature Communications. 11: 2401. PMID 32409639 DOI: 10.1038/s41467-020-15694-y  0.84
2020 Carmona-Gutierrez D, Bauer MA, Zimmermann A, Kainz K, Hofer SJ, Kroemer G, Madeo F. Digesting the crisis: autophagy and coronaviruses. Microbial Cell (Graz, Austria). 7: 119-128. PMID 32391393 DOI: 10.15698/mic2020.05.715  0.88
2020 Vacchelli E, Le Naour J, Kroemer G. The ambiguous role of FPR1 in immunity and inflammation. Oncoimmunology. 9: 1760061. PMID 32391192 DOI: 10.1080/2162402X.2020.1760061  0.92
2020 Buqué A, Bloy N, Kroemer G, Galluzzi L. Potential mechanisms of cancer prevention by nicotinamide. British Journal of Pharmacology. PMID 32383227 DOI: 10.1111/bph.15096  1
2020 Castoldi F, Hyvönen MT, Durand S, Aprahamian F, Sauvat A, Malik SA, Baracco EE, Vacchelli E, Opolon P, Signolle N, Lefevre D, Bossut N, Eisenberg T, Dammbrueck C, Pendl T, ... ... Kroemer G, et al. Chemical activation of SAT1 corrects diet-induced metabolic syndrome. Cell Death and Differentiation. PMID 32376874 DOI: 10.1038/s41418-020-0550-z  0.96
2020 Derosa L, Routy B, Fidelle M, Iebba V, Alla L, Pasolli E, Segata N, Desnoyer A, Pietrantonio F, Ferrere G, Fahrner JE, Le Chatellier E, Pons N, Galleron N, Roume H, ... ... Kroemer G, et al. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients. European Urology. PMID 32376136 DOI: 10.1016/j.eururo.2020.04.044  0.88
2020 Huang Y, Wang H, Hao Y, Lin H, Dong M, Ye J, Song L, Wang Y, Li Q, Shan B, Jiang Y, Li H, Shao Z, Kroemer G, Zhang H, et al. Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity. Nature Cell Biology. PMID 32367047 DOI: 10.1038/s41556-020-0510-3  0.8
2020 Humeau J, Sauvat A, Cerrato G, Xie W, Loos F, Iannantuoni F, Bezu L, Lévesque S, Paillet J, Pol J, Leduc M, Zitvogel L, de Thé H, Kepp O, Kroemer G. Inhibition of transcription by dactinomycin reveals a new characteristic of immunogenic cell stress. Embo Molecular Medicine. e11622. PMID 32323922 DOI: 10.15252/emmm.201911622  0.96
2020 Ravel JM, Monraz Gomez LC, Sompairac N, Calzone L, Zhivotovsky B, Kroemer G, Barillot E, Zinovyev A, Kuperstein I. Comprehensive Map of the Regulated Cell Death Signaling Network: A Powerful Analytical Tool for Studying Diseases. Cancers. 12. PMID 32316560 DOI: 10.3390/cancers12040990  0.52
2020 Chong SJF, Marchi S, Petroni G, Kroemer G, Galluzzi L, Pervaiz S. Noncanonical Cell Fate Regulation by Bcl-2 Proteins. Trends in Cell Biology. PMID 32307222 DOI: 10.1016/j.tcb.2020.03.004  1
2020 Galluzzi L, Kroemer G. Transient Autophagy Inhibition Precipitates Oncogenesis: A Red Flag For Pharmacological Autophagy Inhibitors? Trends in Cell Biology. 30: 339-340. PMID 32302546 DOI: 10.1016/j.tcb.2020.02.004  1
2020 Chen G, Kroemer G, Kepp O. Mitophagy: An Emerging Role in Aging and Age-Associated Diseases. Frontiers in Cell and Developmental Biology. 8: 200. PMID 32274386 DOI: 10.3389/fcell.2020.00200  0.96
2020 Galluzzi L, Petroni G, Kroemer G. Immunogenicity of cell death driven by immune effectors. Journal For Immunotherapy of Cancer. 8. PMID 32253221 DOI: 10.1136/jitc-2020-000802  1
2020 Kroemer G, Pietrocola F. The scent of death: a metabolic goodbye signal emitted by dying cells. Cell Death and Differentiation. PMID 32251367 DOI: 10.1038/s41418-020-0533-0  0.96
2020 Wang Y, Xie W, Humeau J, Chen G, Liu P, Pol J, Zhang Z, Kepp O, Kroemer G. Autophagy induction by thiostrepton improves the efficacy of immunogenic chemotherapy. Journal For Immunotherapy of Cancer. 8. PMID 32221018 DOI: 10.1136/jitc-2019-000462  0.96
2020 Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, ... ... Kroemer G, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal For Immunotherapy of Cancer. 8. PMID 32209603 DOI: 10.1136/jitc-2019-000337  1
2020 Liu J, Kuang F, Kroemer G, Klionsky DJ, Kang R, Tang D. Autophagy-Dependent Ferroptosis: Machinery and Regulation. Cell Chemical Biology. PMID 32160513 DOI: 10.1016/j.chembiol.2020.02.005  0.64
2020 Sica V, Martins I, Motiño O, Bravo-San Pedro JM, Kroemer G. Antibody-mediated neutralization of ACBP/DBI has anorexigenic and lipolytic effects. Adipocyte. 9: 116-119. PMID 32157940 DOI: 10.1080/21623945.2020.1736734  1
2020 Zhang H, Zeng L, Xie M, Liu J, Zhou B, Wu R, Cao L, Kroemer G, Wang H, Billiar TR, Zeh HJ, Kang R, Jiang J, Yu Y, Tang D. TMEM173 Drives Lethal Coagulation in Sepsis. Cell Host & Microbe. PMID 32142632 DOI: 10.1016/j.chom.2020.02.004  0.64
2020 Madeo F, Tavernarakis N, Pedro JMB, Kroemer G. ACBP is an appetite stimulator across phylogenetic barriers. Cell Stress. 4: 27-29. PMID 32043075 DOI: 10.15698/cst2020.02.211  0.88
2020 Liu P, Zhao L, Kroemer G, Kepp O. Secreted calreticulin mutants subvert anticancer immunosurveillance. Oncoimmunology. 9: 1708126. PMID 32002304 DOI: 10.1080/2162402X.2019.1708126  0.96
2020 Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. Oncoimmunology. 9: 1703449. PMID 32002302 DOI: 10.1080/2162402X.2019.1703449  1
2020 Hamy AS, Derosa L, Valdelièvre C, Yonekura S, Opolon P, Priour M, Guerin J, Pierga JY, Asselain B, De Croze D, Pinheiro A, Lae M, Talagrand LS, Laas E, Darrigues L, ... ... Kroemer G, et al. Comedications influence immune infiltration and pathological response to neoadjuvant chemotherapy in breast cancer. Oncoimmunology. 9: 1677427. PMID 32002287 DOI: 10.1080/2162402X.2019.1677427  0.88
2020 Ma Y, Yang H, Kroemer G. Endogenous and exogenous glucocorticoids abolish the efficacy of immune-dependent cancer therapies. Oncoimmunology. 9: 1673635. PMID 32002285 DOI: 10.1080/2162402X.2019.1673635  0.68
2020 Li T, Li K, Zhang S, Wang Y, Xu Y, Cronin SJF, Sun Y, Zhang Y, Xie C, Rodriguez J, Zhou K, Hagberg H, Mallard C, Wang X, Penninger JM, ... Kroemer G, et al. Overexpression of apoptosis inducing factor aggravates hypoxic-ischemic brain injury in neonatal mice. Cell Death & Disease. 11: 77. PMID 32001673 DOI: 10.1038/s41419-020-2280-z  0.68
2020 Cerrato G, Liu P, Martins I, Kepp O, Kroemer G. Quantitative determination of phagocytosis by bone marrow-derived dendritic cells via imaging flow cytometry. Methods in Enzymology. 632: 27-37. PMID 32000900 DOI: 10.1016/bs.mie.2019.07.021  0.96
2020 Kasikova L, Truxova I, Cremer I, Sautes-Fridman C, Kepp O, Kroemer G, Spisek R, Fucikova J. Side-by-side comparison of flow cytometry and immunohistochemistry for detection of calreticulin exposure in the course of immunogenic cell death. Methods in Enzymology. 632: 15-25. PMID 32000894 DOI: 10.1016/bs.mie.2019.05.025  0.96
2020 Liu P, Zhao L, Kepp O, Kroemer G. Quantitation of calreticulin exposure associated with immunogenic cell death. Methods in Enzymology. 632: 1-13. PMID 32000891 DOI: 10.1016/bs.mie.2019.05.011  0.96
2020 Dai E, Han L, Liu J, Xie Y, Kroemer G, Klionsky DJ, Zeh HJ, Kang R, Wang J, Tang D. Autophagy-Dependent Ferroptosis Drives Tumor-Associated Macrophage Polarization via Release and Uptake of Oncogenic KRAS Protein. Autophagy. PMID 31920150 DOI: 10.1080/15548627.2020.1714209  0.64
2020 Charmpilas N, Ruckenstuhl C, Sica V, Büttner S, Habernig L, Dichtinger S, Madeo F, Tavernarakis N, Bravo-San Pedro JM, Kroemer G. Acyl-CoA-binding protein (ACBP): a phylogenetically conserved appetite stimulator. Cell Death & Disease. 11: 7. PMID 31907349 DOI: 10.1038/s41419-019-2205-x  1
2020 Hazari Y, Bravo-San Pedro JM, Hetz C, Galluzzi L, Kroemer G. Autophagy in hepatic adaptation to stress. Journal of Hepatology. 72: 183-196. PMID 31849347 DOI: 10.1016/j.jhep.2019.08.026  1
2019 Bezu L, Chuang AW, Liu P, Kroemer G, Kepp O. Immunological Effects of Epigenetic Modifiers. Cancers. 11. PMID 31805711 DOI: 10.3390/cancers11121911  0.96
2019 Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Kroemer G, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. 30: 1171. PMID 31801056 DOI: 10.1016/j.cmet.2019.10.011  1
2019 Liu P, Zhao L, Loos F, Marty C, Xie W, Martins I, Lachkar S, Qu B, Waeckel-Énée E, Plo I, Vainchenker W, Perez F, Rodriguez D, López-Otin C, van Endert P, ... ... Kroemer G, et al. Immunosuppression by Mutated Calreticulin Released from Malignant Cells. Molecular Cell. PMID 31785928 DOI: 10.1016/j.molcel.2019.11.004  0.96
2019 Gehrmann U, Burbage M, Zueva E, Goudot C, Esnault C, Ye M, Carpier JM, Burgdorf N, Hoyler T, Suarez G, Joannas L, Heurtebise-Chrétien S, Durand S, Panes R, Bellemare-Pelletier A, ... ... Kroemer G, et al. Critical role for TRIM28 and HP1β/γ in the epigenetic control of T cell metabolic reprograming and effector differentiation. Proceedings of the National Academy of Sciences of the United States of America. PMID 31776254 DOI: 10.1073/pnas.1901639116  0.52
2019 Kasikova L, Hensler M, Truxova I, Skapa P, Laco J, Belicova L, Praznovec I, Vosahlikova S, Halaska MJ, Brtnicky T, Rob L, Presl J, Kostun J, Cremer I, Ryska A, ... Kroemer G, et al. Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients. Journal For Immunotherapy of Cancer. 7: 312. PMID 31747968 DOI: 10.1186/s40425-019-0781-z  1
2019 Zhao L, Liu P, Kepp O, Kroemer G. Methods for measuring HMGB1 release during immunogenic cell death. Methods in Enzymology. 629: 177-193. PMID 31727240 DOI: 10.1016/bs.mie.2019.05.001  0.96
2019 Notomi S, Ishihara K, Efstathiou NE, Lee JJ, Hisatomi T, Tachibana T, Konstantinou EK, Ueta T, Murakami Y, Maidana DE, Ikeda Y, Kume S, Terasaki H, Sonoda S, Blanz J, ... ... Kroemer G, et al. Genetic LAMP2 deficiency accelerates the age-associated formation of basal laminar deposits in the retina. Proceedings of the National Academy of Sciences of the United States of America. PMID 31699817 DOI: 10.1073/pnas.1906643116  0.4
2019 Bravo-San Pedro JM, Sica V, Kroemer G. The elusive "hunger protein": an appetite-stimulatory factor that is overabundant in human obesity. Molecular & Cellular Oncology. 6: e1667193. PMID 31692883 DOI: 10.1080/23723556.2019.1667193  1
2019 Kepp O, Chen G, Carmona-Gutierrez D, Madeo F, Kroemer G. A discovery platform for the identification of caloric restriction mimetics with broad health-improving effects. Autophagy. PMID 31690168 DOI: 10.1080/15548627.2019.1688984  0.96
2019 Pedro JMB, Sica V, Madeo F, Kroemer G. Acyl-CoA-binding protein (ACBP): the elusive 'hunger factor' linking autophagy to food intake. Cell Stress. 3: 312-318. PMID 31656948 DOI: 10.15698/cst2019.10.200  1
2019 Lévesque S, Le Naour J, Pietrocola F, Paillet J, Kremer M, Castoldi F, Baracco EE, Wang Y, Vacchelli E, Stoll G, Jolly A, De La Grange P, Zitvogel L, Kroemer G, Pol JG. A synergistic triad of chemotherapy, immune checkpoint inhibitors, and caloric restriction mimetics eradicates tumors in mice. Oncoimmunology. 8: e1657375. PMID 31646107 DOI: 10.1080/2162402X.2019.1657375  0.96
2019 Xie W, Forveille S, Iribarren K, Sauvat A, Senovilla L, Wang Y, Humeau J, Perez-Lanzon M, Zhou H, Martínez-Leal JF, Kroemer G, Kepp O. Lurbinectedin synergizes with immune checkpoint blockade to generate anticancer immunity. Oncoimmunology. 8: e1656502. PMID 31646106 DOI: 10.1080/2162402X.2019.1656502  0.96
2019 Sprooten J, Ceusters J, Coosemans A, Agostinis P, De Vleeschouwer S, Zitvogel L, Kroemer G, Galluzzi L, Garg AD. Trial watch: dendritic cell vaccination for cancer immunotherapy. Oncoimmunology. 8: e1638212. PMID 31646087 DOI: 10.1080/2162402X.2019.1638212  1
2019 Pietrocola F, Kroemer G. Caloric restriction promotes the stemness and antitumor activity of T lymphocytes. Oncoimmunology. 8: e1616153. PMID 31646069 DOI: 10.1080/2162402X.2019.1616153  0.96
2019 Pol JG, Caudana P, Paillet J, Piaggio E, Kroemer G. Effects of interleukin-2 in immunostimulation and immunosuppression. The Journal of Experimental Medicine. PMID 31611250 DOI: 10.1084/jem.20191247  0.44
2019 Chen G, Xie W, Nah J, Sauvat A, Liu P, Pietrocola F, Sica V, Carmona-Gutierrez D, Zimmermann A, Pendl T, Tadic J, Bergmann M, Hofer SJ, Domuz L, Lachkar S, ... ... Kroemer G, et al. 3,4-Dimethoxychalcone induces autophagy through activation of the transcription factors TFE3 and TFEB. Embo Molecular Medicine. e10469. PMID 31609086 DOI: 10.15252/emmm.201910469  1
2019 Bravo-San Pedro JM, Sica V, Kroemer G. Pseudodiabetes-not a contraindication for metabolic interventions. Cell Death & Disease. 10: 765. PMID 31601789 DOI: 10.1038/s41419-019-2007-1  1
2019 Loos F, Xie W, Sica V, Bravo-San Pedro JM, Souquère S, Pierron G, Lachkar S, Sauvat A, Petrazzuolo A, Jimenez AJ, Perez F, Maiuri MC, Kepp O, Kroemer G. Artificial tethering of LC3 or p62 to organelles is not sufficient to trigger autophagy. Cell Death & Disease. 10: 771. PMID 31601788 DOI: 10.1038/s41419-019-2011-5  1
2019 Paoletti A, Allouch A, Caillet M, Saïdi H, Subra F, Nardacci R, Wu Q, Muradova Z, Voisin L, Raza SQ, Law F, Thoreau M, Dakhli H, Delelis O, Poirier-Beaudouin B, ... ... Kroemer G, et al. HIV-1 Envelope Overcomes NLRP3-Mediated Inhibition of F-Actin Polymerization for Viral Entry. Cell Reports. 28: 3381-3394.e7. PMID 31553908 DOI: 10.1016/j.celrep.2019.02.095  0.76
2019 Yang H, Xia L, Chen J, Zhang S, Martin V, Li Q, Lin S, Chen J, Calmette J, Lu M, Fu L, Yang J, Pan Z, Yu K, He J, ... ... Kroemer G, et al. Stress-glucocorticoid-TSC22D3 axis compromises therapy-induced antitumor immunity. Nature Medicine. 25: 1428-1441. PMID 31501614 DOI: 10.1038/s41591-019-0566-4  0.88
2019 Jacquelot N, Yamazaki T, Roberti MP, Duong CPM, Andrews MC, Verlingue L, Ferrere G, Becharef S, Vétizou M, Daillère R, Messaoudene M, Enot DP, Stoll G, Ugel S, Marigo I, ... ... Kroemer G, et al. Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockade. Cell Research. PMID 31481761 DOI: 10.1038/s41422-019-0224-x  0.88
2019 Stekovic S, Hofer SJ, Tripolt N, Aon MA, Royer P, Pein L, Stadler JT, Pendl T, Prietl B, Url J, Schroeder S, Tadic J, Eisenberg T, Magnes C, Stumpe M, ... ... Kroemer G, et al. Alternate Day Fasting Improves Physiological and Molecular Markers of Aging in Healthy, Non-obese Humans. Cell Metabolism. 30: 462-476.e6. PMID 31471173 DOI: 10.1016/j.cmet.2019.07.016  0.88
2019 Bravo-San Pedro JM, Sica V, Martins I, Anagnostopoulos G, Maiuri C, Kroemer G. Cell-autonomous, paracrine and neuroendocrine feedback regulation of autophagy by DBI/ACBP (diazepam binding inhibitor, acyl-CoA binding protein): the obesity factor. Autophagy. PMID 31470770 DOI: 10.1080/15548627.2019.1662585  1
2019 Sica V, Bravo-San Pedro JM, Kroemer G. A strategy for poisoning cancer cell metabolism: Inhibition of oxidative phosphorylation coupled to anaplerotic saturation. International Review of Cell and Molecular Biology. 347: 27-37. PMID 31451215 DOI: 10.1016/bs.ircmb.2019.07.002  1
2019 Bravo-San Pedro JM, Sica V, Martins I, Pol J, Loos F, Maiuri MC, Durand S, Bossut N, Aprahamian F, Anagnostopoulos G, Niso-Santano M, Aranda F, Ramírez-Pardo I, Lallement J, Denom J, ... ... Kroemer G, et al. Acyl-CoA-Binding Protein Is a Lipogenic Factor that Triggers Food Intake and Obesity. Cell Metabolism. PMID 31422903 DOI: 10.1016/j.cmet.2019.07.010  1
2019 Kepp O, Sauvat A, Leduc M, Forveille S, Liu P, Zhao L, Bezu L, Xie W, Zitvogel L, Kroemer G. A fluorescent biosensor-based platform for the discovery of immunogenic cancer cell death inducers. Oncoimmunology. 8: 1606665. PMID 31413915 DOI: 10.1080/2162402X.2019.1606665  0.96
2019 Sica V, Bravo-San Pedro JM, Stoll G, Kroemer G. Oxidative phosphorylation as a potential therapeutic target for cancer therapy. International Journal of Cancer. PMID 31396957 DOI: 10.1002/ijc.32616  1
2019 Deutsch E, Chargari C, Galluzzi L, Kroemer G. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy. The Lancet. Oncology. 20: e452-e463. PMID 31364597 DOI: 10.1016/S1470-2045(19)30171-8  1
2019 Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang D. Clockophagy is a novel selective autophagy process favoring ferroptosis. Science Advances. 5: eaaw2238. PMID 31355331 DOI: 10.1126/sciadv.aaw2238  0.64
2019 Viltard M, Durand S, Pérez-Lanzón M, Aprahamian F, Lefevre D, Leroy C, Madeo F, Kroemer G, Friedlander G. The metabolomic signature of extreme longevity: naked mole rats mice. Aging. PMID 31346149 DOI: 10.18632/aging.102116  0.88
2019 Bárcena C, Valdés-Mas R, Mayoral P, Garabaya C, Durand S, Rodríguez F, Fernández-García MT, Salazar N, Nogacka AM, Garatachea N, Bossut N, Aprahamian F, Lucia A, Kroemer G, Freije JMP, et al. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nature Medicine. PMID 31332389 DOI: 10.1038/s41591-019-0504-5  0.52
2019 Maiuri L, Raia V, Piacentini M, Tosco A, Villella VR, Kroemer G. Cystic fibrosis transmembrane conductance regulator (CFTR) and autophagy: hereditary defects in cystic fibrosis gluten-mediated inhibition in celiac disease. Oncotarget. 10: 4492-4500. PMID 31321000 DOI: 10.18632/oncotarget.27037  0.44
2019 Vitale I, Manic G, Coussens LM, Kroemer G, Galluzzi L. Macrophages and Metabolism in the Tumor Microenvironment. Cell Metabolism. 30: 36-50. PMID 31269428 DOI: 10.1016/j.cmet.2019.06.001  1
2019 Zimmermann A, Kainz K, Hofer SJ, Bauer MA, Schroeder S, Dengjel J, Pietrocola F, Kepp O, Ruckenstuhl C, Eisenberg T, Sigrist SJ, Madeo F, Carmona-Gutierrez D, Kroemer G. 4,4'-Dimethoxychalcone: a natural flavonoid that promotes health through autophagy-dependent and -independent effects. Autophagy. I-3. PMID 31248332 DOI: 10.1080/15548627.2019.1632623  0.96
2019 Deretic V, Prossnitz E, Burge M, Campen MJ, Cannon J, Liu KJ, Hall P, Sklar LA, Allers L, Mariscal L, Garcia SA, Baehrecke EH, Behrends C, Cecconi F, Codogno P, ... ... Kroemer G, et al. Autophagy, Inflammation, and Metabolism (AIM) Center in its second year. Autophagy. PMID 31234750 DOI: 10.1080/15548627.2019.1634444  0.64
2019 Carreras-Sureda A, Jaña F, Urra H, Durand S, Mortenson DE, Sagredo A, Bustos G, Hazari Y, Ramos-Fernández E, Sassano ML, Pihán P, van Vliet AR, González-Quiroz M, Torres AK, Tapia-Rojas C, ... ... Kroemer G, et al. Publisher Correction: Non-canonical function of IRE1α determines mitochondria-associated endoplasmic reticulum composition to control calcium transfer and bioenergetics. Nature Cell Biology. PMID 31201389 DOI: 10.1038/s41556-019-0355-9  0.52
2019 Baracco EE, Castoldi F, Durand S, Enot DP, Tadic J, Kainz K, Madeo F, Chery A, Izzo V, Maiuri MC, Pietrocola F, Kroemer G. α-Ketoglutarate inhibits autophagy. Aging. PMID 31173576 DOI: 10.18632/aging.102001  0.96
2019 Liu P, Zhao L, Kepp O, Kroemer G. Crizotinib - a tyrosine kinase inhibitor that stimulates immunogenic cell death. Oncoimmunology. 8: 1596652. PMID 31143519 DOI: 10.1080/2162402X.2019.1596652  0.96
2019 Xie W, Mondragón L, Mauseth B, Wang Y, Pol J, Lévesque S, Zhou H, Yamazaki T, Eksteen JJ, Zitvogel L, Sveinbjørnsson B, Rekdal Ø, Kepp O, Kroemer G. Tumor lysis with LTX-401 creates anticancer immunity. Oncoimmunology. 8: 1594555. PMID 31143516 DOI: 10.1080/2162402X.2019.1594555  0.96
2019 Lévesque S, Pol JG, Ferrere G, Galluzzi L, Zitvogel L, Kroemer G. Trial watch: dietary interventions for cancer therapy. Oncoimmunology. 8: 1591878. PMID 31143510 DOI: 10.1080/2162402X.2019.1591878  1
2019 Rao S, Mondragón L, Pranjic B, Hanada T, Stoll G, Köcher T, Zhang P, Jais A, Lercher A, Bergthaler A, Schramek D, Haigh K, Sica V, Leduc M, Modjtahedi N, ... ... Kroemer G, et al. AIF-regulated oxidative phosphorylation supports lung cancer development. Cell Research. PMID 31133695 DOI: 10.1038/s41422-019-0181-4  1
2019 Chen R, Zeng L, Zhu S, Liu J, Zeh HJ, Kroemer G, Wang H, Billiar TR, Jiang J, Tang D, Kang R. cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis. Science Advances. 5: eaav5562. PMID 31131320 DOI: 10.1126/sciadv.aav5562  0.64
2019 Zimmermann A, Kainz K, Hofer SJ, Bauer MA, Schroeder S, Dengjel J, Pietrocola F, Kepp O, Ruckenstuhl C, Eisenberg T, Sigrist SJ, Madeo F, Kroemer G, Carmona-Gutierrez D. Targeting GATA transcription factors - a novel strategy for anti-aging interventions? Microbial Cell (Graz, Austria). 6: 212-216. PMID 31114793 DOI: 10.15698/mic2019.05.676  0.96
2019 Carreras-Sureda A, Jaña F, Urra H, Durand S, Mortenson DE, Sagredo A, Bustos G, Hazari Y, Ramos-Fernández E, Sassano ML, Pihán P, van Vliet AR, González-Quiroz M, Torres AK, Tapia-Rojas C, ... ... Kroemer G, et al. Non-canonical function of IRE1α determines mitochondria-associated endoplasmic reticulum composition to control calcium transfer and bioenergetics. Nature Cell Biology. PMID 31110288 DOI: 10.1038/s41556-019-0329-y  0.52
2019 Stoll G, Kremer M, Bloy N, Joseph A, Castedo M, Meurice G, Klein C, Galluzzi L, Michels J, Kroemer G. Metabolic enzymes expressed by cancer cells impact the immune infiltrate. Oncoimmunology. 8: e1571389. PMID 31069148 DOI: 10.1080/2162402X.2019.1571389  1
2019 Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, ... ... Kroemer G, et al. Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1883. PMID 30996258 DOI: 10.1038/s41467-019-09838-y  1
2019 Sica V, Bravo-San Pedro JM, Izzo V, Pol J, Pierredon S, Enot D, Durand S, Bossut N, Chery A, Souquere S, Pierron G, Vartholomaiou E, Zamzami N, Soussi T, Sauvat A, ... ... Kroemer G, et al. Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate. Cell Reports. 27: 820-834.e9. PMID 30995479 DOI: 10.1016/j.celrep.2019.03.058  1
2019 Esposito S, Villella VR, Ferrari E, Monzani R, Tosco A, Rossin F, D'Eletto M, Castaldo A, Luciani A, Silano M, Bona G, Marseglia GL, Romani L, Piacentini M, Raia V, ... Kroemer G, et al. Genistein antagonizes gliadin-induced CFTR malfunction in models of celiac disease. Aging. PMID 30981209 DOI: 10.18632/aging.101888  0.44
2019 Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. PMID 30962044 DOI: 10.1016/j.tcb.2019.03.005  1
2019 Galluzzi L, Kroemer G. Cancer Cells Thrive on Stress. Trends in Cell Biology. 29: 449-451. PMID 30962043 DOI: 10.1016/j.tcb.2019.03.002  1
2019 Tang D, Kang R, Berghe TV, Vandenabeele P, Kroemer G. The molecular machinery of regulated cell death. Cell Research. PMID 30948788 DOI: 10.1038/s41422-019-0164-5  0.64
2019 Zhang S, Wang Y, Xie W, Howe ENW, Busschaert N, Sauvat A, Leduc M, Gomes-da-Silva LC, Chen G, Martins I, Deng X, Maiuri L, Kepp O, Soussi T, Gale PA, ... ... Kroemer G, et al. Author Correction: Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux. Cell Death & Disease. 10: 301. PMID 30944306 DOI: 10.1038/s41419-019-1536-y  1
2019 Liu P, Zhao L, Pol J, Levesque S, Petrazzuolo A, Pfirschke C, Engblom C, Rickelt S, Yamazaki T, Iribarren K, Senovilla L, Bezu L, Vacchelli E, Sica V, Melis A, ... ... Kroemer G, et al. Crizotinib-induced immunogenic cell death in non-small cell lung cancer. Nature Communications. 10: 1486. PMID 30940805 DOI: 10.1038/s41467-019-09415-3  1
2019 Messaoudene M, Mourikis TP, Michels J, Fu Y, Bonvalet M, Lacroix-Trikki M, Routy B, Fluckiger A, Rusakiewicz S, Roberti MP, Cotteret S, Flament C, Poirier-Colame V, Jacquelot N, Ghiringhelli F, ... ... Kroemer G, et al. T cell Bispecific Antibodies in Node-Positive Breast Cancer: Novel Therapeutic Avenue for MHC class I Loss Variants. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30924846 DOI: 10.1093/annonc/mdz112  0.88
2019 Zhou B, Liu J, Kang R, Klionsky DJ, Kroemer G, Tang D. Ferroptosis Is a Type of Autophagy-Dependent Cell Death. Seminars in Cancer Biology. PMID 30880243 DOI: 10.1016/j.semcancer.2019.03.002  0.64
2019 Villella VR, Esposito S, Ferrari E, Monzani R, Tosco A, Rossin F, Castaldo A, Silano M, Marseglia GL, Romani L, Barlev NA, Piacentini M, Raia V, Kroemer G, Maiuri L. Autophagy suppresses the pathogenic immune response to dietary antigens in cystic fibrosis. Cell Death & Disease. 10: 258. PMID 30874543 DOI: 10.1038/s41419-019-1500-x  0.44
2019 Zhang S, Wang Y, Xie W, Howe ENW, Busschaert N, Sauvat A, Leduc M, Gomes-da-Silva LC, Chen G, Martins I, Deng X, Maiuri L, Kepp O, Soussi T, Gale PA, ... ... Kroemer G, et al. Squaramide-based synthetic chloride transporters activate TFEB but block autophagic flux. Cell Death & Disease. 10: 242. PMID 30858361 DOI: 10.1038/s41419-019-1474-8  1
2019 Piacentini M, Kroemer G. Luigi Maiuri: un Grande Uomo - a Great Spirit. Cell Death & Disease. 10: 209. PMID 30824687 DOI: 10.1038/s41419-019-1466-8  0.44
2019 Galluzzi L, Kroemer G. Etiological involvement of CFTR in apparently unrelated human diseases. Molecular & Cellular Oncology. 6: 1558874. PMID 30788425 DOI: 10.1080/23723556.2018.1558874  1
2019 Carmona-Gutierrez D, Zimmermann A, Kainz K, Pietrocola F, Chen G, Maglioni S, Schiavi A, Nah J, Mertel S, Beuschel CB, Castoldi F, Sica V, Trausinger G, Raml R, Sommer C, ... ... Kroemer G, et al. The flavonoid 4,4'-dimethoxychalcone promotes autophagy-dependent longevity across species. Nature Communications. 10: 651. PMID 30783116 DOI: 10.1038/s41467-019-08555-w  1
2019 Maiuri L, Villella VR, Piacentini M, Raia V, Kroemer G. Defective proteostasis in celiac disease as a new therapeutic target. Cell Death & Disease. 10: 114. PMID 30737369 DOI: 10.1038/s41419-019-1392-9  0.44
2019 Iribarren K, Buque A, Mondragon L, Xie W, Lévesque S, Pol J, Zitvogel L, Kepp O, Kroemer G. Anticancer effects of anti-CD47 immunotherapy . Oncoimmunology. 8: 1550619. PMID 30723582 DOI: 10.1080/2162402X.2018.1550619  0.96
2019 Levine B, Kroemer G. Biological Functions of Autophagy Genes: A Disease Perspective. Cell. 176: 11-42. PMID 30633901 DOI: 10.1016/j.cell.2018.09.048  0.6
2019 Dajon M, Iribarren K, Petitprez F, Marmier S, Lupo A, Gillard M, Ouakrim H, Victor N, Vincenzo DB, Joubert PE, Kepp O, Kroemer G, Alifano M, Damotte D, Cremer I. Toll like receptor 7 expressed by malignant cells promotes tumor progression and metastasis through the recruitment of myeloid derived suppressor cells. Oncoimmunology. 8: e1505174. PMID 30546943 DOI: 10.1080/2162402X.2018.1505174  0.96
2019 Castoldi F, Vacchelli E, Zitvogel L, Maiuri MC, Pietrocola F, Kroemer G. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. Oncoimmunology. 8: e1498285. PMID 30546941 DOI: 10.1080/2162402X.2018.1498285  0.96
2019 Humeau J, Lévesque S, Kroemer G, Pol JG. Gold Standard Assessment of Immunogenic Cell Death in Oncological Mouse Models. Methods in Molecular Biology (Clifton, N.J.). 1884: 297-315. PMID 30465212 DOI: 10.1007/978-1-4939-8885-3_21  0.72
2018 Rodriguez J, Zhang Y, Li T, Xie C, Sun Y, Xu Y, Zhou K, Huo K, Wang Y, Wang X, Andersson D, Ståhlberg A, Xing Q, Mallard C, Hagberg H, ... ... Kroemer G, et al. Lack of the brain-specific isoform of apoptosis-inducing factor aggravates cerebral damage in a model of neonatal hypoxia-ischemia. Cell Death & Disease. 10: 3. PMID 30584234 DOI: 10.1038/s41419-018-1250-1  0.68
2018 Pechlaner R, Madeo F, Eisenberg T, Kroemer G, Tilg H, Willeit J, Kiechl S. Reply to Gostner and Fuchs. The American Journal of Clinical Nutrition. PMID 30576412 DOI: 10.1093/ajcn/nqy222  0.88
2018 Castedo M, Obrist F, Kroemer G. Cisplatin resistance coupled to enhanced sensitivity to metabolic interventions. Molecular & Cellular Oncology. 5: e1526004. PMID 30525097 DOI: 10.1080/23723556.2018.1526004  0.96
2018 Galluzzi L, Kroemer G. Potent immunosuppressive effects of the oncometabolite -2-hydroxyglutarate. Oncoimmunology. 7: e1528815. PMID 30524910 DOI: 10.1080/2162402X.2018.1528815  1
2018 Smith M, García-Martínez E, Pitter MR, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in cancer immunotherapy. Oncoimmunology. 7: e1526250. PMID 30524908 DOI: 10.1080/2162402X.2018.1526250  1
2018 Bezu L, Kepp O, Cerrato G, Pol J, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Peptide-based vaccines in anticancer therapy. Oncoimmunology. 7: e1511506. PMID 30524907 DOI: 10.1080/2162402X.2018.1511506  1
2018 G Pol J, Lévesque S, Workenhe ST, Gujar S, Le Boeuf F, R Clements D, Fahrner JE, Fend L, C Bell J, L Mossman K, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. Oncoimmunology. 7: e1503032. PMID 30524901 DOI: 10.1080/2162402X.2018.1503032  1
2018 Ivagnès A, Messaoudene M, Stoll G, Routy B, Fluckiger A, Yamazaki T, Iribarren K, Duong CPM, Fend L, Caignard A, Cremer I, LeCesne A, Adam J, Honoré C, Mir O, ... ... Kroemer G, et al. TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer. Oncoimmunology. 7: e1386826. PMID 30524877 DOI: 10.1080/2162402X.2017.1386826  0.88
2018 López-Soto A, Kroemer G. Cancer-Induced Endoplasmic Reticulum Stress in T Cells Subverts Immunosurveillance. Cell Metabolism. 28: 803-805. PMID 30517892 DOI: 10.1016/j.cmet.2018.11.003  0.48
2018 Marchi S, Corricelli M, Branchini A, Vitto VAM, Missiroli S, Morciano G, Perrone M, Ferrarese M, Giorgi C, Pinotti M, Galluzzi L, Kroemer G, Pinton P. Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca levels and tumor growth. The Embo Journal. PMID 30504268 DOI: 10.15252/embj.201899435  1
2018 Villella VR, Venerando A, Cozza G, Esposito S, Ferrari E, Monzani R, Spinella MC, Oikonomou V, Renga G, Tosco A, Rossin F, Guido S, Silano M, Garaci E, Chao YK, ... ... Kroemer G, et al. A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease. The Embo Journal. PMID 30498130 DOI: 10.15252/embj.2018100101  0.44
2018 Polishchuk EV, Merolla A, Lichtmannegger J, Romano A, Indrieri A, Ilyechova EY, Concilli M, De Cegli R, Crispino R, Mariniello M, Petruzzelli R, Ranucci G, Iorio R, Pietrocola F, Einer C, ... ... Kroemer G, et al. Activation of autophagy, observed in liver tissues from patients with Wilson disease and from Atp7b-deficient animals, protects hepatocytes from copper-induced apoptosis. Gastroenterology. PMID 30452922 DOI: 10.1053/j.gastro.2018.11.032  0.96
2018 Sixt BS, Núñez-Otero C, Kepp O, Valdivia RH, Kroemer G. Chlamydia trachomatis fails to protect its growth niche against pro-apoptotic insults. Cell Death and Differentiation. PMID 30375511 DOI: 10.1038/s41418-018-0224-2  0.96
2018 Abdellatif M, Sedej S, Carmona-Gutierrez D, Madeo F, Kroemer G. Autophagy in Cardiovascular Aging. Circulation Research. 123: 803-824. PMID 30355077 DOI: 10.1161/CIRCRESAHA.118.312208  0.88
2018 Pietrocola F, Castoldi F, Kepp O, Carmona-Gutierrez D, Madeo F, Kroemer G. Spermidine reduces cancer-related mortality in humans. Autophagy. 1-4. PMID 30354939 DOI: 10.1080/15548627.2018.1539592  0.96
2018 Zhou H, Mondragón L, Xie W, Mauseth B, Leduc M, Sauvat A, Gomes-da-Silva LC, Forveille S, Iribarren K, Souquere S, Bezu L, Liu P, Zhao L, Zitvogel L, Sveinbjørnsson B, ... ... Kroemer G, et al. Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals. Cell Death & Disease. 9: 1086. PMID 30352991 DOI: 10.1038/s41419-018-1127-3  0.96
2018 Gomes-da-Silva LC, Jimenez AJ, Sauvat A, Xie W, Souquere S, Divoux S, Storch M, Sveinbjørnsson B, Rekdal Ø, Arnaut LG, Kepp O, Kroemer G, Perez F. Recruitment of LC3 to damaged Golgi apparatus. Cell Death and Differentiation. PMID 30349077 DOI: 10.1038/s41418-018-0221-5  0.96
2018 Kroemer G, López-Otín C, Madeo F, de Cabo R. Carbotoxicity-Noxious Effects of Carbohydrates. Cell. 175: 605-614. PMID 30340032 DOI: 10.1016/j.cell.2018.07.044  0.88
2018 Elkrief A, Derosa L, Zitvogel L, Kroemer G, Routy B. The intimate relationship between gut microbiota and cancer immunotherapy. Gut Microbes. 1-5. PMID 30339501 DOI: 10.1080/19490976.2018.1527167  0.88
2018 Madeo F, Bauer MA, Carmona-Gutierrez D, Kroemer G. Spermidine: a physiological autophagy inducer acting as an anti-aging vitamin in humans? Autophagy. 1-4. PMID 30306826 DOI: 10.1080/15548627.2018.1530929  0.88
2018 Galluzzi L, Yamazaki T, Kroemer G. Linking cellular stress responses to systemic homeostasis. Nature Reviews. Molecular Cell Biology. PMID 30305710 DOI: 10.1038/s41580-018-0068-0  1
2018 Zhao L, Liu P, Boncompain G, Loos F, Lachkar S, Bezu L, Chen G, Zhou H, Perez F, Kepp O, Kroemer G. Identification of pharmacological inhibitors of conventional protein secretion. Scientific Reports. 8: 14966. PMID 30297865 DOI: 10.1038/s41598-018-33378-y  0.96
2018 Stoll G, Pol J, Soumelis V, Zitvogel L, Kroemer G. Impact of chemotactic factors and receptors on the cancer immune infiltrate: a bioinformatics study revealing homogeneity and heterogeneity among patient cohorts. Oncoimmunology. 7: e1484980. PMID 30288345 DOI: 10.1080/2162402X.2018.1484980  0.88
2018 Galluzzi L, Chan TA, Kroemer G, Wolchok JD, López-Soto A. The hallmarks of successful anticancer immunotherapy. Science Translational Medicine. 10. PMID 30232229 DOI: 10.1126/scitranslmed.aat7807  1
2018 Enot DP, Vacchelli E, Jacquelot N, Zitvogel L, Kroemer G. TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves. Oncoimmunology. 7: e1462431. PMID 30228932 DOI: 10.1080/2162402X.2018.1462431  0.92
2018 Aranda F, Chaba K, Bloy N, Garcia P, Bordenave C, Martins I, Stoll G, Tesniere A, Kroemer G, Senovilla L. Immune effectors responsible for the elimination of hyperploid cancer cells. Oncoimmunology. 7: e1463947. PMID 30221060 DOI: 10.1080/2162402X.2018.1463947  0.92
2018 Bonora M, Wieckowski MR, Sinclair DA, Kroemer G, Pinton P, Galluzzi L. Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles. Nature Reviews. Cardiology. PMID 30177752 DOI: 10.1038/s41569-018-0074-0  1
2018 Bárcena C, Quirós PM, Durand S, Mayoral P, Rodríguez F, Caravia XM, Mariño G, Garabaya C, Fernández-García MT, Kroemer G, Freije JMP, López-Otín C. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism. Cell Reports. 24: 2392-2403. PMID 30157432 DOI: 10.1016/j.celrep.2018.07.089  0.8
2018 Gomes-da-Silva LC, Zhao L, Arnaut LG, Kroemer G, Kepp O. Redaporfin induces immunogenic cell death by selective destruction of the endoplasmic reticulum and the Golgi apparatus. Oncotarget. 9: 31169-31170. PMID 30131844 DOI: 10.18632/oncotarget.25798  0.96
2018 Boland B, Yu WH, Corti O, Mollereau B, Henriques A, Bezard E, Pastores GM, Rubinsztein DC, Nixon RA, Duchen MR, Mallucci GR, Kroemer G, Levine B, Eskelinen EL, Mochel F, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing. Nature Reviews. Drug Discovery. PMID 30116051 DOI: 10.1038/nrd.2018.109  0.6
2018 Li C, Zhang Y, Cheng X, Yuan H, Zhu S, Liu J, Wen Q, Xie Y, Liu J, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang D. PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Developmental Cell. PMID 30100261 DOI: 10.1016/j.devcel.2018.07.012  0.64
2018 Madeo F, Gutierrez DC, Kepp O, Kroemer G. Spermidine delays aging in humans. Aging. PMID 30082504 DOI: 10.18632/aging.101517  0.96
2018 Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, Xie Y, Liu J, Klionsky DJ, Kroemer G, Lotze MT, Zeh HJ, Kang R, Tang D. AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X Activity. Current Biology : Cb. PMID 30057310 DOI: 10.1016/j.cub.2018.05.094  0.72
2018 Kiechl S, Pechlaner R, Willeit P, Notdurfter M, Paulweber B, Willeit K, Werner P, Ruckenstuhl C, Iglseder B, Weger S, Mairhofer B, Gartner M, Kedenko L, Chmelikova M, Stekovic S, ... ... Kroemer G, et al. Higher spermidine intake is linked to lower mortality: a prospective population-based study. The American Journal of Clinical Nutrition. PMID 29955838 DOI: 10.1093/ajcn/nqy102  0.88
2018 Deretic V, Prossnitz E, Burge M, Campen MJ, Cannon J, Liu KJ, Sklar LA, Allers L, Garcia SA, Baehrecke EH, Behrends C, Cecconi F, Codogno P, Chen GC, Elazar Z, ... ... Kroemer G, et al. Autophagy, Inflammation, and Metabolism (AIM) Center of Biomedical Research Excellence: supporting the next generation of autophagy researchers and fostering international collaborations. Autophagy. PMID 29938597 DOI: 10.1080/15548627.2018.1465784  0.64
2018 Kang R, Zeng L, Zhu S, Xie Y, Liu J, Wen Q, Cao L, Xie M, Ran Q, Kroemer G, Wang H, Billiar TR, Jiang J, Tang D. Lipid Peroxidation Drives Gasdermin D-Mediated Pyroptosis in Lethal Polymicrobial Sepsis. Cell Host & Microbe. PMID 29937272 DOI: 10.1016/j.chom.2018.05.009  0.64
2018 Pietrocola F, Castoldi F, Maiuri MC, Kroemer G. Aspirin-another caloric-restriction mimetic. Autophagy. PMID 29929449 DOI: 10.1080/15548627.2018.1454810  0.96
2018 Sica V, Kroemer G. Author Correction: IMMP2L: a mitochondrial protease suppressing cellular senescence. Cell Research. PMID 29921919 DOI: 10.1038/s41422-018-0059-x  1
2018 Martins I, Raza SQ, Voisin L, Dakhli H, Allouch A, Law F, Sabino D, De Jong D, Thoreau M, Mintet E, Dugué D, Piacentini M, Gougeon ML, Jaulin F, Bertrand P, ... ... Kroemer G, et al. Anticancer chemotherapy and radiotherapy trigger both non-cell-autonomous and cell-autonomous death. Cell Death & Disease. 9: 716. PMID 29915308 DOI: 10.1038/s41419-018-0747-y  0.92
2018 Obrist F, Michels J, Durand S, Chery A, Pol J, Levesque S, Joseph A, Astesana V, Pietrocola F, Wu GS, Castedo M, Kroemer G. Metabolic vulnerability of cisplatin-resistant cancers. The Embo Journal. PMID 29875130 DOI: 10.15252/embj.201798597  0.96
2018 Derosa L, Routy B, Kroemer G, Zitvogel L. The intestinal microbiota determines the clinical efficacy of immune checkpoint blockers targeting PD-1/PD-L1. Oncoimmunology. 7: e1434468. PMID 29872574 DOI: 10.1080/2162402X.2018.1434468  0.88
2018 García-Martínez E, Smith M, Buqué A, Aranda F, de la Peña FA, Ivars A, Cánovas MS, Conesa MAV, Fucikova J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with recombinant cytokines for cancer therapy. Oncoimmunology. 7: e1433982. PMID 29872569 DOI: 10.1080/2162402X.2018.1433982  1
2018 Liu P, Zhao L, Loos F, Iribarren K, Kepp O, Kroemer G. Epigenetic anticancer agents cause HMGB1 release . Oncoimmunology. 7: e1431090. PMID 29872561 DOI: 10.1080/2162402X.2018.1431090  0.96
2018 Bezu L, Sauvat A, Humeau J, Leduc M, Kepp O, Kroemer G. eIF2α phosphorylation: A hallmark of immunogenic cell death. Oncoimmunology. 7: e1431089. PMID 29872560 DOI: 10.1080/2162402X.2018.1431089  0.96
2018 Yang M, Li C, Zhu S, Cao L, Kroemer G, Zeh H, Tang D, Kang R. TFAM is a novel mediator of immunogenic cancer cell death. Oncoimmunology. 7: e1431086. PMID 29872558 DOI: 10.1080/2162402X.2018.1431086  0.64
2018 Castoldi F, Pietrocola F, Maiuri MC, Kroemer G. Aspirin induces autophagy inhibition of the acetyltransferase EP300. Oncotarget. 9: 24574-24575. PMID 29872488 DOI: 10.18632/oncotarget.25364  0.96
2018 Sica V, Kroemer G. IMMP2L: a mitochondrial protease suppressing cellular senescence. Cell Research. PMID 29844577 DOI: 10.1038/s41422-018-0051-5  1
2018 Gomes-da-Silva LC, Zhao L, Bezu L, Zhou H, Sauvat A, Liu P, Durand S, Leduc M, Souquere S, Loos F, Mondragón L, Sveinbjørnsson B, Rekdal Ø, Boncompain G, Perez F, ... ... Kroemer G, et al. Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus. The Embo Journal. PMID 29807932 DOI: 10.15252/embj.201798354  0.96
2018 Kang R, Kroemer G, Tang D. The Tumor Suppressor Protein p53 and the Ferroptosis Network. Free Radical Biology & Medicine. PMID 29800655 DOI: 10.1016/j.freeradbiomed.2018.05.074  0.64
2018 Rossin F, Villella VR, D'Eletto M, Farrace MG, Esposito S, Ferrari E, Monzani R, Occhigrossi L, Pagliarini V, Sette C, Cozza G, Barlev NA, Falasca L, Fimia GM, Kroemer G, et al. TG2 regulates the heat-shock response by the post-translational modification of HSF1. Embo Reports. PMID 29752334 DOI: 10.15252/embr.201745067  0.44
2018 Routy B, Gopalakrishnan V, Daillère R, Zitvogel L, Wargo JA, Kroemer G. The gut microbiota influences anticancer immunosurveillance and general health. Nature Reviews. Clinical Oncology. PMID 29636538 DOI: 10.1038/s41571-018-0006-2  0.88
2018 Sauvat A, Chen G, Müller K, Tong M, Aprahamian F, Durand S, Cerrato G, Bezu L, Leduc M, Franz J, Rockenfeller P, Sadoshima J, Madeo F, Kepp O, Kroemer G. Trans-Fats Inhibit Autophagy Induced by Saturated Fatty Acids. Ebiomedicine. PMID 29606629 DOI: 10.1016/j.ebiom.2018.03.028  0.96
2018 Pol J, Kroemer G. Anti-CTLA-4 immunotherapy: uncoupling toxicity and efficacy. Cell Research. 28: 501-502. PMID 29593340 DOI: 10.1038/s41422-018-0031-9  0.68
2018 Zitvogel L, Ma Y, Raoult D, Kroemer G, Gajewski TF. The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic strategies. Science (New York, N.Y.). 359: 1366-1370. PMID 29567708 DOI: 10.1126/science.aar6918  0.88
2018 Perez-Lanzon M, Kroemer G, Maiuri MC. Organoids for Modeling Genetic Diseases. International Review of Cell and Molecular Biology. 337: 49-81. PMID 29551162 DOI: 10.1016/bs.ircmb.2017.12.006  0.96
2018 Pietrocola F, Castoldi F, Markaki M, Lachkar S, Chen G, Enot DP, Durand S, Bossut N, Tong M, Malik SA, Loos F, Dupont N, Mariño G, Abdelkader N, Madeo F, ... ... Kroemer G, et al. Aspirin Recapitulates Features of Caloric Restriction. Cell Reports. 22: 2395-2407. PMID 29490275 DOI: 10.1016/j.celrep.2018.02.024  0.96
2018 Rybstein MD, Bravo-San Pedro JM, Kroemer G, Galluzzi L. The autophagic network and cancer. Nature Cell Biology. 20: 243-251. PMID 29476153 DOI: 10.1038/s41556-018-0042-2  1
2018 Zhang S, Stoll G, Pedro JMBS, Sica V, Sauvat A, Obrist F, Kepp O, Li Y, Maiuri L, Zamzami N, Kroemer G. Evaluation of autophagy inducers in epithelial cells carrying the ΔF508 mutation of the cystic fibrosis transmembrane conductance regulator CFTR. Cell Death & Disease. 9: 191. PMID 29415993 DOI: 10.1038/s41419-017-0235-9  1
2018 Kroemer G, Zitvogel L. Cancer immunotherapy in 2017: The breakthrough of the microbiota. Nature Reviews. Immunology. 18: 87-88. PMID 29379189 DOI: 10.1038/nri.2018.4  0.88
2018 Madeo F, Eisenberg T, Pietrocola F, Kroemer G. Spermidine in health and disease. Science (New York, N.Y.). 359. PMID 29371440 DOI: 10.1126/science.aan2788  0.96
2018 Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, ... ... Kroemer G, et al. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death and Differentiation. PMID 29362479 DOI: 10.1038/s41418-017-0012-4  1
2018 Bezu L, Sauvat A, Humeau J, Gomes-da-Silva LC, Iribarren K, Forveille S, Garcia P, Zhao L, Liu P, Zitvogel L, Senovilla L, Kepp O, Kroemer G. eIF2α phosphorylation is pathognomonic for immunogenic cell death. Cell Death and Differentiation. PMID 29358668 DOI: 10.1038/s41418-017-0044-9  0.96
2018 Carmona-Gutierrez D, Bauer MA, Zimmermann A, Aguilera A, Austriaco N, Ayscough K, Balzan R, Bar-Nun S, Barrientos A, Belenky P, Blondel M, Braun RJ, Breitenbach M, Burhans WC, Büttner S, ... ... Kroemer G, et al. Guidelines and recommendations on yeast cell death nomenclature. Microbial Cell (Graz, Austria). 5: 4-31. PMID 29354647 DOI: 10.15698/mic2018.01.607  1
2018 Gyrd-Hansen M, Farkas T, Fehrenbacher N, Bastholm L, Høyer-Hansen M, Elling F, Wallach D, Flavell R, Kroemer G, Nylandsted J, Jäättelä M. Correction for Gyrd-Hansen et al., "Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway by Caspase-9". Molecular and Cellular Biology. 38. PMID 29288151 DOI: 10.1128/MCB.00563-17  0.44
2017 Kroemer G, Galluzzi L. Lysosome-targeting agents in cancer therapy. Oncotarget. 8: 112168-112169. PMID 29348815 DOI: 10.18632/oncotarget.21451  1
2017 Pitt JM, Kroemer G, Zitvogel L. Immunogenic and Non-immunogenic Cell Death in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1036: 65-79. PMID 29275465 DOI: 10.1007/978-3-319-67577-0_5  0.88
2017 Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng D, Wang P, Ma X, Kroemer G, Bartlett DL, Billiar TR, Lotze M, Zeh H, Kang R, Tang D. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. Gastroenterology. PMID 29248440 DOI: 10.1053/j.gastro.2017.12.004  0.72
2017 Ring J, Rockenfeller P, Abraham C, Tadic J, Poglitsch M, Schimmel K, Westermayer J, Schauer S, Achleitner B, Schimpel C, Moitzi B, Rechberger GN, Sigrist SJ, Carmona-Gutierrez D, Kroemer G, et al. Mitochondrial energy metabolism is required for lifespan extension by the spastic paraplegia-associated protein spartin. Microbial Cell (Graz, Austria). 4: 411-422. PMID 29234670 DOI: 10.15698/mic2017.12.603  0.88
2017 Rockenfeller P, Smolnig M, Diessl J, Bashir M, Schmiedhofer V, Knittelfelder O, Ring J, Franz J, Foessl I, Khan MJ, Rost R, Graier WF, Kroemer G, Zimmermann A, Carmona-Gutierrez D, et al. Diacylglycerol triggers Rim101 pathway-dependent necrosis in yeast: a model for lipotoxicity. Cell Death and Differentiation. PMID 29230001 DOI: 10.1038/s41418-017-0014-2  0.88
2017 Porporato PE, Filigheddu N, Bravo-San Pedro JM, Kroemer G, Galluzzi L. Mitochondrial metabolism and cancer. Cell Research. PMID 29219147 DOI: 10.1038/cr.2017.155  1
2017 Pierini S, Perales-Linares R, Uribe-Herranz M, Pol JG, Zitvogel L, Kroemer G, Facciabene A, Galluzzi L. Trial watch: DNA-based vaccines for oncological indications. Oncoimmunology. 6: e1398878. PMID 29209575 DOI: 10.1080/2162402X.2017.1398878  1
2017 Garg AD, More S, Rufo N, Mece O, Sassano ML, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics. Oncoimmunology. 6: e1386829. PMID 29209573 DOI: 10.1080/2162402X.2017.1386829  1
2017 Cabo M, Offringa R, Zitvogel L, Kroemer G, Muntasell A, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. Oncoimmunology. 6: e1371896. PMID 29209572 DOI: 10.1080/2162402X.2017.1371896  1
2017 Sica V, Bravo-San Pedro JM, Chen G, Mariño G, Lachkar S, Izzo V, Maiuri MC, Niso-Santano M, Kroemer G. Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy. Oncotarget. 8: 89527-89538. PMID 29163768 DOI: 10.18632/oncotarget.19033  1
2017 Vanpouille-Box C, Lhuillier C, Bezu L, Aranda F, Yamazaki T, Kepp O, Fucikova J, Spisek R, Demaria S, Formenti SC, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immune checkpoint blockers for cancer therapy. Oncoimmunology. 6: e1373237. PMID 29147629 DOI: 10.1080/2162402X.2017.1373237  1
2017 Fournier C, Martin F, Zitvogel L, Kroemer G, Galluzzi L, Apetoh L. Trial Watch: Adoptively transferred cells for anticancer immunotherapy. Oncoimmunology. 6: e1363139. PMID 29147628 DOI: 10.1080/2162402X.2017.1363139  1
2017 Zhou H, Sauvat A, Gomes-da-Silva LC, Durand S, Forveille S, Iribarren K, Yamazaki T, Souquere S, Bezu L, Müller K, Leduc M, Liu P, Zhao L, Marabelle A, Zitvogel L, ... ... Kroemer G, et al. The oncolytic compound LTX-401 targets the Golgi apparatus. Cell Death and Differentiation. PMID 29125604 DOI: 10.1038/cdd.2017.148  0.96
2017 Liu P, Zhao L, Loos F, Iribarren K, Lachkar S, Zhou H, Gomes-da-Silva LC, Chen G, Bezu L, Boncompain G, Perez F, Zitvogel L, Kepp O, Kroemer G. Identification of pharmacological agents that induce HMGB1 release. Scientific Reports. 7: 14915. PMID 29097772 DOI: 10.1038/s41598-017-14848-1  0.96
2017 Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, Fidelle M, Flament C, Poirier-Colame V, Opolon P, Klein C, ... ... Kroemer G, et al. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science (New York, N.Y.). PMID 29097494 DOI: 10.1126/science.aan3706  0.88
2017 Bloy N, Garcia P, Laumont CM, Pitt JM, Sistigu A, Stoll G, Yamazaki T, Bonneil E, Buqué A, Humeau J, Drijfhout JW, Meurice G, Walter S, Fritsche J, Weinschenk T, ... ... Kroemer G, et al. Immunogenic stress and death of cancer cells: Contribution of antigenicity vs adjuvanticity to immunosurveillance. Immunological Reviews. 280: 165-174. PMID 29027230 DOI: 10.1111/imr.12582  0.88
2017 Kepp O, Loos F, Liu P, Kroemer G. Extracellular nucleosides and nucleotides as immunomodulators. Immunological Reviews. 280: 83-92. PMID 29027229 DOI: 10.1111/imr.12571  0.96
2017 Biselli E, Agliari E, Barra A, Bertani FR, Gerardino A, De Ninno A, Mencattini A, Di Giuseppe D, Mattei F, Schiavoni G, Lucarini V, Vacchelli E, Kroemer G, Di Natale C, Martinelli E, et al. Organs on chip approach: a tool to evaluate cancer -immune cells interactions. Scientific Reports. 7: 12737. PMID 28986543 DOI: 10.1038/s41598-017-13070-3  0.92
2017 Bantug GR, Galluzzi L, Kroemer G, Hess C. The spectrum of T cell metabolism in health and disease. Nature Reviews. Immunology. PMID 28944771 DOI: 10.1038/nri.2017.99  1
2017 López-Soto A, Gonzalez S, López-Larrea C, Kroemer G. Immunosurveillance of Malignant Cells with Complex Karyotypes. Trends in Cell Biology. PMID 28939156 DOI: 10.1016/j.tcb.2017.09.001  0.48
2017 Maiuri L, Raia V, Kroemer G. Strategies for the etiological therapy of cystic fibrosis. Cell Death and Differentiation. PMID 28937684 DOI: 10.1038/cdd.2017.126  0.32
2017 Stoll G, Caron B, Viara E, Dugourd A, Zinovyev A, Naldi A, Kroemer G, Barillot E, Calzone L. MaBoSS 2.0: an environment for stochastic Boolean modeling. Bioinformatics (Oxford, England). 33: 2226-2228. PMID 28881959 DOI: 10.1093/bioinformatics/btx123  0.6
2017 Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, Lotze MT, Zeh HJ, Kang R, Kroemer G, Tang D. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Reports. 20: 1692-1704. PMID 28813679 DOI: 10.1016/j.celrep.2017.07.055  0.72
2017 Garg AD, Vara Perez M, Schaaf M, Agostinis P, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer immunotherapy. Oncoimmunology. 6: e1328341. PMID 28811970 DOI: 10.1080/2162402X.2017.1328341  1
2017 Humeau J, Bravo-San Pedro JM, Vitale I, Nuñez L, Villalobos C, Kroemer G, Senovilla L. Calcium signaling and cell cycle: Progression or death. Cell Calcium. PMID 28801101 DOI: 10.1016/j.ceca.2017.07.006  0.88
2017 Fernández ÁF, Bárcena C, Martínez-García GG, Tamargo-Gómez I, Suárez MF, Pietrocola F, Castoldi F, Esteban L, Sierra-Filardi E, Boya P, López-Otín C, Kroemer G, Mariño G. Autophagy couteracts weight gain, lipotoxicity and pancreatic β-cell death upon hypercaloric pro-diabetic regimens. Cell Death & Disease. 8: e2970. PMID 28771229 DOI: 10.1038/cddis.2017.373  0.96
2017 Xie Y, Zhu S, Zhong M, Yang M, Sun X, Liu J, Kroemer G, Lotze M, Zeh HJ, Kang R, Tang D. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Gastroenterology. PMID 28764929 DOI: 10.1053/j.gastro.2017.07.036  0.64
2017 Fridman WH, Zitvogel L, Sautès-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nature Reviews. Clinical Oncology. PMID 28741618 DOI: 10.1038/nrclinonc.2017.101  0.88
2017 Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer. Nature Immunology. 18: 843-850. PMID 28722707 DOI: 10.1038/ni.3754  0.96
2017 Galluzzi L, Kroemer G. Secondary Necrosis: Accidental No More. Trends in Cancer. 3: 1-2. PMID 28718422 DOI: 10.1016/j.trecan.2016.12.001  1
2017 Sica V, Bravo-San Pedro JM, Chen G, Mariño G, Lachkar S, Izzo V, Maiuri MC, Niso-Santano M, Kroemer G. Inhibitor of growth protein 4 interacts with Beclin 1 and represses autophagy. Oncotarget. PMID 28706153 DOI: 10.18632/oncotarget.19033  1
2017 Galluzzi L, Kroemer G. Novel immune checkpoint blocker to treat Merkel cell carcinoma. Oncoimmunology. 6: e1315496. PMID 28680746 DOI: 10.1080/2162402X.2017.1315496  1
2017 Stekovic S, Ruckenstuhl C, Royer P, Winkler-Hermaden C, Carmona-Gutierrez D, Fröhlich KU, Kroemer G, Madeo F. The neuroprotective steroid progesterone promotes mitochondrial uncoupling, reduces cytosolic calcium and augments stress resistance in yeast cells. Microbial Cell (Graz, Austria). 4: 191-199. PMID 28660203 DOI: 10.15698/mic2017.06.577  0.88
2017 Galluzzi L, Kroemer G. An epigenetic modifier triggers therapeutic immune responses against breast cancer. Oncoimmunology. 6: e1313376. PMID 28638742 DOI: 10.1080/2162402X.2017.1313376  1
2017 Vitale I, Manic G, Castedo M, Kroemer G. Caspase 2 in mitotic catastrophe: The terminator of aneuploid and tetraploid cells. Molecular & Cellular Oncology. 4: e1299274. PMID 28616577 DOI: 10.1080/23723556.2017.1299274  0.96
2017 Pietrocola F, Bravo-San Pedro JM, Galluzzi L, Kroemer G. Autophagy in natural and therapy-driven anticancer immunosurveillance. Autophagy. 0. PMID 28598229 DOI: 10.1080/15548627.2017.1310356  1
2017 Galluzzi L, Baehrecke EH, Ballabio A, Boya P, Bravo-San Pedro JM, Cecconi F, Choi AM, Chu CT, Codogno P, Colombo MI, Cuervo AM, Debnath J, Deretic V, Dikic I, Eskelinen EL, ... ... Kroemer G, et al. Molecular definitions of autophagy and related processes. The Embo Journal. PMID 28596378 DOI: 10.15252/embj.201796697  1
2017 Bonora M, Morganti C, Morciano G, Pedriali G, Lebiedzinska-Arciszewska M, Aquila G, Giorgi C, Rizzo P, Campo G, Ferrari R, Kroemer G, Wieckowski MR, Galluzzi L, Pinton P. Mitochondrial permeability transition involves dissociation of F1FO ATP synthase dimers and C-ring conformation. Embo Reports. PMID 28566520 DOI: 10.15252/embr.201643602  1
2017 Bravo-San Pedro JM, Kroemer G, Galluzzi L. Autophagy and Mitophagy in Cardiovascular Disease. Circulation Research. 120: 1812-1824. PMID 28546358 DOI: 10.1161/CIRCRESAHA.117.311082  1
2017 Fend L, Yamazaki T, Remy C, Fahrner C, Gantzer M, Nourtier V, Préville X, Quéméneur E, Kepp O, Adam J, Marabelle A, Pitt JM, Kroemer G, Zitvogel L. Immune checkpoint blockade, immunogenic chemotherapy or IFN-α blockade boost the local and abscopal effects of oncolytic virotherapy. Cancer Research. PMID 28536278 DOI: 10.1158/0008-5472.CAN-16-2165  0.96
2017 Zitvogel L, Daillère R, Roberti MP, Routy B, Kroemer G. Anticancer effects of the microbiome and its products. Nature Reviews. Microbiology. PMID 28529325 DOI: 10.1038/nrmicro.2017.44  0.88
2017 Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nature Reviews. Drug Discovery. PMID 28529316 DOI: 10.1038/nrd.2017.22  1
2017 Stoll G, Ma Y, Yang H, Kepp O, Zitvogel L, Kroemer G. Pro-necrotic molecules impact local immunosurveillance in human breast cancer. Oncoimmunology. 6: e1299302. PMID 28507808 DOI: 10.1080/2162402X.2017.1299302  0.96
2017 Sun Y, Li T, Xie C, Xu Y, Zhou K, Rodriguez J, Han W, Wang X, Kroemer G, Modjtahedi N, Blomgren K, Zhu C. Haploinsufficiency in the mitochondrial protein CHCHD4 reduces brain injury in a mouse model of neonatal hypoxia-ischemia. Cell Death & Disease. 8: e2781. PMID 28492551 DOI: 10.1038/cddis.2017.196  0.68
2017 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: Immunosuppressive cell death in cancer. Nature Reviews. Immunology. PMID 28480896 DOI: 10.1038/nri.2017.48  1
2017 Vitale I, Manic G, De Maria R, Kroemer G, Galluzzi L. DNA Damage in Stem Cells. Molecular Cell. 66: 306-319. PMID 28475867 DOI: 10.1016/j.molcel.2017.04.006  1
2017 Esteban-Martínez L, Sierra-Filardi E, McGreal RS, Salazar-Roa M, Mariño G, Seco E, Durand S, Enot D, Graña O, Malumbres M, Cvekl A, Cuervo AM, Kroemer G, Boya P. Programmed mitophagy is essential for the glycolytic switch during cell differentiation. The Embo Journal. PMID 28465321 DOI: 10.15252/embj.201695916  0.8
2017 Fezai M, Slaymi C, Ben-Attia M, Kroemer G, Lang F, Jemaà M. Inhibition of Colon Carcinoma Cell Migration Following Treatment with Purified Venom from Lesser Weever Fish (Trachinus Vipera). Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology. 41: 2279-2288. PMID 28456793 DOI: 10.1159/000475646  0.72
2017 Galluzzi L, Kroemer G. Calreticulin and type I interferon: An unsuspected connection. Oncoimmunology. 6: e1288334. PMID 28405522 DOI: 10.1080/2162402X.2017.1288334  1
2017 Joseph B, Marchetti P, Formstecher P, Kroemer G, Lewensohn R, Zhivotovsky B. Mitochondrial dysfunction is an essential step for killing of non-small cell lung carcinomas resistant to conventional treatment. Oncogene. PMID 28394341 DOI: 10.1038/onc.2017.78  0.52
2017 Galluzzi L, Bravo-San Pedro JM, Kroemer G. [Autophagy, fitness and longevity]. Medecine Sciences : M/S. 33: 246-251. PMID 28367810 DOI: 10.1051/medsci/20173303010  1
2017 Codogno P, Kroemer G. [Be oneself eatable, in moderation, a condition to keep a healthy spirit in a healthy body]. Medecine Sciences : M/S. 33: 213-214. PMID 28367802 DOI: 10.1051/medsci/20173303002  0.44
2017 Vitale I, Kroemer G. Spontaneous DNA damage propels tumorigenicity. Cell Research. PMID 28361897 DOI: 10.1038/cr.2017.43  0.88
2017 Sauvat A, Zhou H, Leduc M, Gomes-da-Silva LC, Bezu L, Müller K, Forveille S, Liu P, Zhao L, Kroemer G, Kepp O. Automated Analysis of Fluorescence Colocalization: Application to Mitophagy. Methods in Enzymology. 588: 219-230. PMID 28237103 DOI: 10.1016/bs.mie.2016.09.082  0.96
2017 Fend L, Rusakiewicz S, Adam J, Bastien B, Caignard A, Messaoudene M, Iribarren C, Cremer I, Marabelle A, Borg C, Semeraro M, Barraud L, Limacher JM, Eggermont A, Kroemer G, et al. Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer. Oncoimmunology. 6: e1163456. PMID 28197362 DOI: 10.1080/2162402X.2016.1163456  0.88
2017 Pietrocola F, Kroemer G. Metformin: a metabolic modulator. Oncotarget. PMID 28122334 DOI: 10.18632/oncotarget.14794  0.96
2017 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Mitophagy: Permitted by Prohibitin. Current Biology : Cb. 27: R73-R76. PMID 28118594 DOI: 10.1016/j.cub.2016.11.055  1
2017 Eisenberg T, Abdellatif M, Zimmermann A, Schroeder S, Pendl T, Harger A, Stekovic S, Schipke J, Magnes C, Schmidt A, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, Carmona-Gutierrez D, ... ... Kroemer G, et al. Dietary spermidine for lowering high blood pressure. Autophagy. 0. PMID 28118075 DOI: 10.1080/15548627.2017.1280225  0.96
2017 López-Soto A, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Gonzalez S. Involvement of autophagy in NK cell development and function. Autophagy. 0. PMID 28103115 DOI: 10.1080/15548627.2016.1274486  1
2017 Ferrari E, Monzani R, Villella VR, Esposito S, Saluzzo F, Rossin F, D'Eletto M, Tosco A, De Gregorio F, Izzo V, Maiuri MC, Kroemer G, Raia V, Maiuri L. Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation. Cell Death & Disease. 8: e2544. PMID 28079883 DOI: 10.1038/cddis.2016.476  0.96
2017 Izzo V, Pietrocola F, Sica V, Durand S, Lachkar S, Enot D, Bravo-San Pedro JM, Chery A, Esposito S, Raia V, Maiuri L, Maiuri MC, Kroemer G. Metabolic interactions between cysteamine and epigallocatechin gallate. Cell Cycle (Georgetown, Tex.). 0. PMID 28059601 DOI: 10.1080/15384101.2016.1249550  1
2017 Pietrocola F, Demont Y, Castoldi F, Enot D, Durand S, Semeraro M, Baracco EE, Pol J, Bravo-San Pedro JM, Bordenave C, Levesque S, Humeau J, Chery A, Métivier D, Madeo F, ... ... Kroemer G, et al. Metabolic effects of fasting on human and mouse blood in vivo. Autophagy. 0. PMID 28059587 DOI: 10.1080/15548627.2016.1271513  0.96
2017 Senovilla L, Demont Y, Humeau J, Bloy N, Kroemer G. Image Cytofluorometry for the Quantification of Ploidy and Endoplasmic Reticulum Stress in Cancer Cells. Methods in Molecular Biology (Clifton, N.J.). 1524: 53-64. PMID 27815895 DOI: 10.1007/978-1-4939-6603-5_3  0.88
2017 Moya A, Larochette N, Paquet J, Deschepper M, Bensidhoum M, Izzo V, Kroemer G, Petite H, Logeart-Avramoglou D. Quiescence Preconditioned Human Multipotent Stromal Cells Adopt a Metabolic Profile Favorable for Enhanced Survival under Ischemia. Stem Cells (Dayton, Ohio). 35: 181-196. PMID 27578059 DOI: 10.1002/stem.2493  0.76
2016 Galluzzi L, Kepp O, Kroemer G. Mitochondrial regulation of cell death: a phylogenetically conserved control. Microbial Cell (Graz, Austria). 3: 101-108. PMID 28357340 DOI: 10.15698/mic2016.03.483  1
2016 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Reply: The complement system is also important in immunogenic cell death. Nature Reviews. Immunology. PMID 28028312 DOI: 10.1038/nri.2016.143  1
2016 Mondragón L, Kroemer G, Galluzzi L. Immunosuppressive γδ T cells foster pancreatic carcinogenesis. Oncoimmunology. 5: e1237328. PMID 27999755 DOI: 10.1080/2162402X.2016.1237328  1
2016 Kroemer G, Galluzzi L. Autophagy-dependent danger signaling and adaptive immunity to poorly immunogenic tumors. Oncotarget. PMID 27974686 DOI: 10.18632/oncotarget.13892  1
2016 Galluzzi L, Kepp O, Chan FK, Kroemer G. Necroptosis: Mechanisms and Relevance to Disease. Annual Review of Pathology. PMID 27959630 DOI: 10.1146/annurev-pathol-052016-100247  1
2016 Catani JP, Medrano RF, Hunger A, Del Valle P, Adjemian S, Zanatta DB, Kroemer G, Costanzi-Strauss E, Strauss BE. Intratumoral Immunization by p19Arf and Interferon-β Gene Transfer in a Heterotopic Mouse Model of Lung Carcinoma. Translational Oncology. 9: 565-574. PMID 27916291 DOI: 10.1016/j.tranon.2016.09.011  0.92
2016 Soussi T, Kroemer G. TP53 and 53BP1 Reunited. Trends in Cell Biology. PMID 27866833 DOI: 10.1016/j.tcb.2016.10.004  0.56
2016 Semeraro M, Adam J, Stoll G, Louvet E, Chaba K, Poirier-Colame V, Sauvat A, Senovilla L, Vacchelli E, Bloy N, Humeau J, Buque A, Kepp O, Zitvogel L, André F, ... ... Kroemer G, et al. The ratio of CD8(+)/FOXP3 T lymphocytes infiltrating breast tissues predicts the relapse of ductal carcinoma in situ. Oncoimmunology. 5: e1218106. PMID 27853639 DOI: 10.1080/2162402X.2016.1218106  0.96
2016 Galluzzi L, Pedro JM, Demaria S, Formenti SC, Kroemer G. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nature Reviews. Clinical Oncology. PMID 27845767 DOI: 10.1038/nrclinonc.2016.183  1
2016 Eisenberg T, Abdellatif M, Schroeder S, Primessnig U, Stekovic S, Pendl T, Harger A, Schipke J, Zimmermann A, Schmidt A, Tong M, Ruckenstuhl C, Dammbrueck C, Gross AS, Herbst V, ... ... Kroemer G, et al. Cardioprotection and lifespan extension by the natural polyamine spermidine. Nature Medicine. PMID 27841876 DOI: 10.1038/nm.4222  0.96
2016 Galluzzi L, Zitvogel L, Kroemer G. Immunological Mechanisms Underneath the Efficacy of Cancer Therapy. Cancer Immunology Research. 4: 895-902. PMID 27803050 DOI: 10.1158/2326-6066.CIR-16-0197  1
2016 Fucikova J, Truxova I, Hensler M, Becht E, Kasikova L, Moserova I, Vosahlikova S, Klouckova J, Church SE, Cremer I, Kepp O, Kroemer G, Galluzzi L, Salek C, Spisek R. Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients. Blood. PMID 27802968 DOI: 10.1182/blood-2016-08-731737  1
2016 Vacchelli E, Bloy N, Aranda F, Buqué A, Cremer I, Demaria S, Eggermont A, Formenti SC, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, et al. Trial Watch: Immunotherapy plus radiation therapy for oncological indications. Oncoimmunology. 5: e1214790. PMID 27757313 DOI: 10.1080/2162402X.2016.1214790  1
2016 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunogenic cell death in cancer and infectious disease. Nature Reviews. Immunology. PMID 27748397 DOI: 10.1038/nri.2016.107  1
2016 Wiraswati HL, Hangen E, Sanz AB, Lam NV, Reinhardt C, Sauvat A, Mogha A, Ortiz A, Kroemer G, Modjtahedi N. Apoptosis inducing factor (AIF) mediates lethal redox stress induced by menadione. Oncotarget. PMID 27738311 DOI: 10.18632/oncotarget.12562  0.72
2016 Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CP, Flament C, Lepage P, Roberti MP, Routy B, Jacquelot N, Apetoh L, Becharef S, Rusakiewicz S, ... ... Kroemer G, et al. Enterococcus hirae and Barnesiella intestinihominis Facilitate Cyclophosphamide-Induced Therapeutic Immunomodulatory Effects. Immunity. PMID 27717798 DOI: 10.1016/j.immuni.2016.09.009  0.88
2016 Zitvogel L, Pitt JM, Daillère R, Smyth MJ, Kroemer G. Mouse models in oncoimmunology. Nature Reviews. Cancer. PMID 27687979 DOI: 10.1038/nrc.2016.91  0.88
2016 Tortola L, Nitsch R, Bertrand MJ, Kogler M, Redouane Y, Kozieradzki I, Uribesalgo I, Fennell LM, Daugaard M, Klug H, Wirnsberger G, Wimmer R, Perlot T, Sarao R, Rao S, ... ... Kroemer G, et al. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate. Cell Reports. 16: 3414. PMID 27653700 DOI: 10.1016/j.celrep.2016.08.072  0.48
2016 Galluzzi L, Kroemer G. Aberrant ketolysis fuels hepatocellular cancer progression. Cell Research. 26: 1077-1078. PMID 27644988 DOI: 10.1038/cr.2016.110  1
2016 Stoll G, Iribarren K, Michels J, Leary A, Zitvogel L, Cremer I, Kroemer G. Calreticulin expression: Interaction with the immune infiltrate and impact on survival in patients with ovarian and non-small cell lung cancer. Oncoimmunology. 5: e1177692. PMID 27622029 DOI: 10.1080/2162402X.2016.1177692  0.88
2016 Zhou H, Sauvat A, Gomes-da-Silva LC, Durand S, Forveille S, Iribarren K, Yamazaki T, Souquere S, Bezu L, Müller K, Leduc M, Liu P, Zhao L, Marabelle A, Zitvogel L, ... ... Kroemer G, et al. The oncolytic compound LTX-401 targets the Golgi apparatus. Cell Death and Differentiation. PMID 27588704 DOI: 10.1038/cdd.2016.86  0.96
2016 Pietrocola F, Pol J, Kroemer G. Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells. Cell Cycle (Georgetown, Tex.). 15: 3327-3328. PMID 27588357 DOI: 10.1080/15384101.2016.1224797  0.96
2016 Missiroli S, Bonora M, Patergnani S, Poletti F, Perrone M, Gafà R, Magri E, Raimondi A, Lanza G, Tacchetti C, Kroemer G, Pandolfi PP, Pinton P, Giorgi C. PML at Mitochondria-Associated Membranes Is Critical for the Repression of Autophagy and Cancer Development. Cell Reports. 16: 2415-27. PMID 27545895 DOI: 10.1016/j.celrep.2016.07.082  0.4
2016 Pietrocola F, Pol J, Vacchelli E, Baracco EE, Levesque S, Castoldi F, Maiuri MC, Madeo F, Kroemer G. Autophagy induction for the treatment of cancer. Autophagy. 12: 1962-1964. PMID 27532519 DOI: 10.1080/15548627.2016.1214778  0.96
2016 López-Otín C, Galluzzi L, Freije JM, Madeo F, Kroemer G. Metabolic Control of Longevity. Cell. 166: 802-21. PMID 27518560 DOI: 10.1016/j.cell.2016.07.031  1
2016 Pitt JM, Vétizou M, Waldschmitt N, Kroemer G, Chamaillard M, Boneca IG, Zitvogel L. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome. Cancer Research. PMID 27474734 DOI: 10.1158/0008-5472.CAN-16-0448  0.88
2016 Ladoire S, Enot D, Senovilla L, Chaix M, Zitvogel L, Kroemer G. Positive impact of autophagy in human breast cancer cells on local immunosurveillance. Oncoimmunology. 5: e1174801. PMID 27471653 DOI: 10.1080/2162402X.2016.1174801  0.88
2016 Ladoire S, Senovilla L, Enot D, Ghiringhelli F, Poirier-Colame V, Chaba K, Erdag G, Schaefer JT, Deacon DH, Zitvogel L, Slingluff CL, Kroemer G. Biomarkers of immunogenic stress in metastases from melanoma patients: Correlations with the immune infiltrate. Oncoimmunology. 5: e1160193. PMID 27471635 DOI: 10.1080/2162402X.2016.1160193  0.64
2016 Buqué A, Bloy N, Aranda F, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy. Oncoimmunology. 5: e1149674. PMID 27471617 DOI: 10.1080/2162402X.2016.1149674  1
2016 Yang H, Ma Y, Chen G, Zhou H, Yamazaki T, Klein C, Pietrocola F, Vacchelli E, Souquere S, Sauvat A, Zitvogel L, Kepp O, Kroemer G. Contribution of RIP3 and MLKL to immunogenic cell death signaling in cancer chemotherapy. Oncoimmunology. 5: e1149673. PMID 27471616 DOI: 10.1080/2162402X.2016.1149673  0.96
2016 Baracco EE, Pietrocola F, Buqué A, Bloy N, Senovilla L, Zitvogel L, Vacchelli E, Kroemer G. Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancer. Oncoimmunology. 5: e1139275. PMID 27471610 DOI: 10.1080/2162402X.2016.1139275  0.96
2016 Kroemer G, Galluzzi L, Zitvogel L. STAT3 inhibition for cancer therapy: Cell-autonomous effects only? Oncoimmunology. 5: e1126063. PMID 27467938 DOI: 10.1080/2162402X.2015.1126063  1
2016 Vacchelli E, Ma Y, Baracco EE, Zitvogel L, Kroemer G. Yet another pattern recognition receptor involved in the chemotherapy-induced anticancer immune response: Formyl peptide receptor-1. Oncoimmunology. 5: e1118600. PMID 27467929 DOI: 10.1080/2162402X.2015.1118600  0.92
2016 Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, ... ... Kroemer G, et al. A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Cell Death and Differentiation. PMID 27447111 DOI: 10.1038/cdd.2016.43  0.96
2016 Pietrocola F, Pol J, Vacchelli E, Rao S, Enot DP, Baracco EE, Levesque S, Castoldi F, Jacquelot N, Yamazaki T, Senovilla L, Marino G, Aranda F, Durand S, Sica V, ... ... Kroemer G, et al. Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance. Cancer Cell. 30: 147-60. PMID 27411589 DOI: 10.1016/j.ccell.2016.05.016  0.64
2016 Pitt JM, Vétizou M, Daillère R, Roberti MP, Yamazaki T, Routy B, Lepage P, Boneca IG, Chamaillard M, Kroemer G, Zitvogel L. Resistance Mechanisms to Immune-Checkpoint Blockade in Cancer: Tumor-Intrinsic and -Extrinsic Factors. Immunity. 44: 1255-69. PMID 27332730 DOI: 10.1016/j.immuni.2016.06.001  0.88
2016 Zitvogel L, Kroemer G. Unchaining NK cell-mediated anticancer immunosurveillance. Nature Immunology. 17: 746-7. PMID 27327996 DOI: 10.1038/ni.3471  0.88
2016 Galluzzi L, Buqué A, Kroemer G. Prevention of breast cancer by RANKL/RANK blockade. Cell Research. 26: 751-2. PMID 27325297 DOI: 10.1038/cr.2016.79  1
2016 Lichtmannegger J, Leitzinger C, Wimmer R, Schmitt S, Schulz S, Kabiri Y, Eberhagen C, Rieder T, Janik D, Neff F, Straub BK, Schirmacher P, DiSpirito AA, Bandow N, Baral BS, ... ... Kroemer G, et al. Methanobactin reverses acute liver failure in a rat model of Wilson disease. The Journal of Clinical Investigation. PMID 27322060 DOI: 10.1172/JCI85226  0.6
2016 Modjtahedi N, Kroemer G. CHCHD4 links AIF to the biogenesis of respiratory chain complex I. Molecular & Cellular Oncology. 3: e1074332. PMID 27308594 DOI: 10.1080/23723556.2015.1074332  0.64
2016 Rockenfeller P, Carmona-Gutierrez D, Pietrocola F, Kroemer G, Madeo F. Ethanolamine: A novel anti-aging agent. Molecular & Cellular Oncology. 3: e1019023. PMID 27308532 DOI: 10.1080/23723556.2015.1019023  0.96
2016 Galluzzi L, Bravo-San Pedro JM, Blomgren K, Kroemer G. Autophagy in acute brain injury. Nature Reviews. Neuroscience. 17: 467-84. PMID 27256553 DOI: 10.1038/nrn.2016.51  1
2016 Sica V, Manic G, Kroemer G, Vitale I, Galluzzi L. Cytofluorometric Quantification of Cell Death Elicited by NLR Proteins. Methods in Molecular Biology (Clifton, N.J.). 1417: 231-45. PMID 27221495 DOI: 10.1007/978-1-4939-3566-6_17  1
2016 Galluzzi L, Kroemer G. A four-lane highway to cancer. Nature Reviews. Molecular Cell Biology. 17: 398. PMID 27220642 DOI: 10.1038/nrm.2016.73  1
2016 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Defective Autophagy Initiates Malignant Transformation. Molecular Cell. 62: 473-4. PMID 27203173 DOI: 10.1016/j.molcel.2016.05.001  1
2016 Vacchelli E, Enot DP, Pietrocola F, Zitvogel L, Kroemer G. Impact of Pattern Recognition Receptors on the Prognosis of Breast Cancer Patients Undergoing Adjuvant Chemotherapy. Cancer Research. 76: 3122-6. PMID 27197163 DOI: 10.1158/0008-5472.CAN-16-0294  0.96
2016 Izzo V, Bravo-San Pedro JM, Sica V, Kroemer G, Galluzzi L. Mitochondrial Permeability Transition: New Findings and Persisting Uncertainties. Trends in Cell Biology. 26: 655-67. PMID 27161573 DOI: 10.1016/j.tcb.2016.04.006  1
2016 Tortola L, Nitsch R, Bertrand MJ, Kogler M, Redouane Y, Kozieradzki I, Uribesalgo I, Fennell LM, Daugaard M, Klug H, Wirnsberger G, Wimmer R, Perlot T, Sarao R, Rao S, ... ... Kroemer G, et al. The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate. Cell Reports. PMID 27160902 DOI: 10.1016/j.celrep.2016.04.032  0.64
2016 Iribarren K, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Špíšek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulation with Toll-like receptor agonists in cancer therapy. Oncoimmunology. 5: e1088631. PMID 27141345 DOI: 10.1080/2162402X.2015.1088631  1
2016 Marabelle A, Routy B, Michels J, Kroemer G, Zitvogel L. Prime time for immune-checkpoint targeted therapy at ASCO 2015. Oncoimmunology. 5: e1068494. PMID 27141332 DOI: 10.1080/2162402X.2015.1068494  0.88
2016 Sica V, Maiuri MC, Kroemer G, Galluzzi L. Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry. Methods in Molecular Biology (Clifton, N.J.). 1419: 1-16. PMID 27108427 DOI: 10.1007/978-1-4939-3581-9_1  1
2016 Galluzzi L, Kroemer G. Amino acid deprivation promotes intestinal homeostasis through autophagy. Oncotarget. 7: 29877-8. PMID 27105494 DOI: 10.18632/oncotarget.8841  1
2016 Yamazaki T, Pitt JM, Vétizou M, Marabelle A, Flores C, Rekdal Ø, Kroemer G, Zitvogel L. The oncolytic peptide LTX-315 overcomes resistance of cancers to immunotherapy with CTLA4 checkpoint blockade. Cell Death and Differentiation. PMID 27082453 DOI: 10.1038/cdd.2016.35  0.64
2016 Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L. Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 27069014 DOI: 10.1093/annonc/mdw168  0.88
2016 Zitvogel L, Ayyoub M, Routy B, Kroemer G. Microbiome and Anticancer Immunosurveillance. Cell. 165: 276-87. PMID 27058662 DOI: 10.1016/j.cell.2016.03.001  0.88
2016 Pol J, Buqué A, Aranda F, Bloy N, Cremer I, Eggermont A, Erbs P, Fucikova J, Galon J, Limacher JM, Preville X, Sautès-Fridman C, Spisek R, Zitvogel L, Kroemer G, et al. Trial Watch-Oncolytic viruses and cancer therapy. Oncoimmunology. 5: e1117740. PMID 27057469 DOI: 10.1080/2162402X.2015.1117740  1
2016 Vacchelli E, Aranda F, Bloy N, Buqué A, Cremer I, Eggermont A, Fridman WH, Fucikova J, Galon J, Spisek R, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch-Immunostimulation with cytokines in cancer therapy. Oncoimmunology. 5: e1115942. PMID 27057468 DOI: 10.1080/2162402X.2015.1115942  1
2016 Ladoire S, Enot D, Andre F, Zitvogel L, Kroemer G. Immunogenic cell death-related biomarkers: Impact on the survival of breast cancer patients after adjuvant chemotherapy. Oncoimmunology. 5: e1082706. PMID 27057465 DOI: 10.1080/2162402X.2015.1082706  0.88
2016 Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, Kroemer G. Improvement of immunogenic chemotherapy by STAT3 inhibition. Oncoimmunology. 5: e1078061. PMID 27057456 DOI: 10.1080/2162402X.2015.1078061  0.96
2016 Stoll G, Zitvogel L, Kroemer G. Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis. Oncoimmunology. 5: e1067746. PMID 27057431 DOI: 10.1080/2162402X.2015.1067746  0.88
2016 Vacchelli E, Semeraro M, Adam J, Dartigues P, Zitvogel L, Kroemer G. Immunosurveillance in esophageal carcinoma: The decisive impact of regulatory T cells. Oncoimmunology. 5: e1064581. PMID 27057430 DOI: 10.1080/2162402X.2015.1064581  0.92
2016 Galluzzi L, Bravo-San Pedro JM, Kepp O, Kroemer G. Regulated cell death and adaptive stress responses. Cellular and Molecular Life Sciences : Cmls. 73: 2405-10. PMID 27048813 DOI: 10.1007/s00018-016-2209-y  1
2016 Vakifahmetoglu-Norberg H, Kim M, Xia HG, Iwanicki MP, Ofengeim D, Coloff JL, Pan L, Ince TA, Kroemer G, Brugge JS, Yuan J. Corrigendum: Chaperone-mediated autophagy degrades mutant p53. Genes & Development. 30: 870. PMID 27036968 DOI: 10.1101/gad.280453.116  0.6
2016 Pitt JM, André F, Amigorena S, Soria JC, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell-derived exosomes for cancer therapy. The Journal of Clinical Investigation. 126: 1224-32. PMID 27035813 DOI: 10.1172/JCI81137  0.88
2016 Pitt JM, Kroemer G, Zitvogel L. Extracellular vesicles: masters of intercellular communication and potential clinical interventions. The Journal of Clinical Investigation. 126: 1139-43. PMID 27035805 DOI: 10.1172/JCI87316  0.88
2016 Tosco A, De Gregorio F, Esposito S, De Stefano D, Sana I, Ferrari E, Sepe A, Salvadori L, Buonpensiero P, Di Pasqua A, Grassia R, Leone CA, Guido S, De Rosa G, Lusa S, ... ... Kroemer G, et al. A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR. Cell Death and Differentiation. PMID 27035618 DOI: 10.1038/cdd.2016.22  0.96
2016 Zitvogel L, Rusakiewicz S, Routy B, Ayyoub M, Kroemer G. Immunological off-target effects of imatinib. Nature Reviews. Clinical Oncology. 13: 431-46. PMID 27030078 DOI: 10.1038/nrclinonc.2016.41  0.88
2016 Kohrt HE, Tumeh PC, Benson D, Bhardwaj N, Brody J, Formenti S, Fox BA, Galon J, June CH, Kalos M, Kirsch I, Kleen T, Kroemer G, Lanier L, Levy R, et al. Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials. Journal For Immunotherapy of Cancer. 4: 15. PMID 26981245 DOI: 10.1186/s40425-016-0118-0  0.88
2016 Ladoire S, Enot D, Senovilla L, Ghiringhelli F, Poirier-Colame V, Chaba K, Semeraro M, Chaix M, Penault-Llorca F, Arnould L, Poillot ML, Arveux P, Delaloge S, Andre F, Zitvogel L, ... Kroemer G, et al. The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer. Autophagy. 12: 864-75. PMID 26979828 DOI: 10.1080/15548627.2016.1154244  0.88
2016 Esposito S, Tosco A, Villella VR, Raia V, Kroemer G, Maiuri L. Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis. Molecular and Cellular Pediatrics. 3: 13. PMID 26976279 DOI: 10.1186/s40348-016-0040-z  0.32
2016 Zhou H, Forveille S, Sauvat A, Yamazaki T, Senovilla L, Ma Y, Liu P, Yang H, Bezu L, Müller K, Zitvogel L, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 triggers immunogenic cell death. Cell Death & Disease. 7: e2134. PMID 26962684 DOI: 10.1038/cddis.2016.47  0.96
2016 Pol J, Kroemer G, Galluzzi L. First oncolytic virus approved for melanoma immunotherapy. Oncoimmunology. 5: e1115641. PMID 26942095 DOI: 10.1080/2162402X.2015.1115641  1
2016 Galluzzi L, Eggermont A, Kroemer G. Doubling the blockade for melanoma immunotherapy. Oncoimmunology. 5: e1106127. PMID 26942094 DOI: 10.1080/2162402X.2015.1106127  1
2016 Ma Y, Yang H, Pitt JM, Kroemer G, Zitvogel L. Therapy-induced microenvironmental changes in cancer. Journal of Molecular Medicine (Berlin, Germany). PMID 26931513 DOI: 10.1007/s00109-016-1401-8  0.4
2016 Mollereau B, Rzechorzek NM, Roussel BD, Sedru M, Van den Brink D, Bailly-Maitre B, Palladino F, Medinas DB, Domingos PM, Hunot S, Chandran S, Birman S, Baron T, Vivien D, Duarte CB, ... ... Kroemer G, et al. Adaptive Preconditioning in Neurological Diseases - Therapeutic Insights from Proteostatic Perturbations. Brain Research. PMID 26923166 DOI: 10.1016/j.brainres.2016.02.033  0.64
2016 Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis. Immunity. 44: 221-31. PMID 26885855 DOI: 10.1016/j.immuni.2016.01.020  1
2016 Pfirschke C, Engblom C, Rickelt S, Cortez-Retamozo V, Garris C, Pucci F, Yamazaki T, Poirier-Colame V, Newton A, Redouane Y, Lin YJ, Wojtkiewicz G, Iwamoto Y, Mino-Kenudson M, Huynh TG, ... ... Kroemer G, et al. Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy. Immunity. 44: 343-354. PMID 26872698 DOI: 10.1016/j.immuni.2015.11.024  0.4
2016 Jacquelot N, Enot DP, Flament C, Vimond N, Blattner C, Pitt JM, Yamazaki T, Roberti MP, Daillère R, Vétizou M, Poirier-Colame V, Semeraro M, Caignard A, Slingluff CL, Sallusto F, ... ... Kroemer G, et al. Chemokine receptor patterns in lymphocytes mirror metastatic spreading in melanoma. The Journal of Clinical Investigation. PMID 26854930 DOI: 10.1172/JCI80071  0.4
2016 Fucikova J, Becht E, Iribarren K, Goc J, Remark R, Damotte D, Alifano M, Devi P, Biton J, Germain C, Lupo A, Fridman WH, Dieu-Nosjean MC, Kroemer G, Sautès-Fridman C, et al. Calreticulin Expression in Human Non-Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis. Cancer Research. 76: 1746-56. PMID 26842877 DOI: 10.1158/0008-5472.CAN-15-1142  0.8
2016 Jacquelot N, Roberti MP, Enot DP, Rusakiewicz S, Semeraro M, Jégou S, Flores C, Chen L, Kwon BS, Borg C, Weide B, Aubin F, Dalle S, Kohrt H, Ayyoub M, ... Kroemer G, et al. Immunophenotyping of stage III melanoma reveals parameters associated with patient prognosis. The Journal of Investigative Dermatology. PMID 26829031 DOI: 10.1016/j.jid.2015.12.042  0.88
2016 Modjtahedi N, Tokatlidis K, Dessen P, Kroemer G. Mitochondrial Proteins Containing Coiled-Coil-Helix-Coiled-Coil-Helix (CHCH) Domains in Health and Disease. Trends in Biochemical Sciences. 41: 245-60. PMID 26782138 DOI: 10.1016/j.tibs.2015.12.004  0.64
2016 Xie C, Ginet V, Sun Y, Koike M, Zhou K, Li T, Li H, Li Q, Wang X, Uchiyama Y, Truttmann AC, Kroemer G, Puyal J, Blomgren K, Zhu C. Neuroprotection by selective neuronal deletion of Atg7 in neonatal brain injury. Autophagy. 0. PMID 26727396 DOI: 10.1080/15548627.2015.1132134  0.72
2016 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Autophagy Mediates Tumor Suppression via Cellular Senescence. Trends in Cell Biology. 26: 1-3. PMID 26612212 DOI: 10.1016/j.tcb.2015.11.001  1
2016 Hermanova I, Arruabarrena-Aristorena A, Valis K, Nuskova H, Alberich-Jorda M, Fiser K, Fernandez-Ruiz S, Kavan D, Pecinova A, Niso-Santano M, Zaliova M, Novak P, Houstek J, Mracek T, Kroemer G, et al. Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells Leukemia. 30: 209-218. PMID 26239197 DOI: 10.1038/leu.2015.213  0.64
2016 Galluzzi L, López-Soto A, Kumar S, Kroemer G. Caspases Connect Cell-Death Signaling to Organismal Homeostasis Immunity. 44: 221-231. DOI: 10.1016/j.immuni.2016.01.020  0.64
2015 Vitale I, Manic G, Senovilla L, Kroemer G, Galluzzi L. Karyotypic Aberrations in Oncogenesis and Cancer Therapy. Trends in Cancer. 1: 124-135. PMID 28741522 DOI: 10.1016/j.trecan.2015.08.001  1
2015 Braun RJ, Sommer C, Leibiger C, Gentier RJ, Dumit VI, Paduch K, Eisenberg T, Habernig L, Trausinger G, Magnes C, Pieber T, Sinner F, Dengjel J, Leeuwen FW, Kroemer G, et al. Modeling non-hereditary mechanisms of Alzheimer disease during apoptosis in yeast. Microbial Cell (Graz, Austria). 2: 136-138. PMID 28357285 DOI: 10.15698/mic2015.04.199  0.88
2015 Obrist F, Manic G, Kroemer G, Vitale I, Galluzzi L. Trial Watch: Proteasomal inhibitors for anticancer therapy. Molecular & Cellular Oncology. 2: e974463. PMID 27308423 DOI: 10.4161/23723556.2014.974463  1
2015 Senovilla L, Kroemer G. Chemosensitization strategies for the treatment of lung cancer. Oncoscience. 2: 833-4. PMID 26682268 DOI: 10.18632/oncoscience.208  0.88
2015 Galluzzi L, Buqué A, Kepp O, Zitvogel L, Kroemer G. Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents. Cancer Cell. 28: 690-714. PMID 26678337 DOI: 10.1016/j.ccell.2015.10.012  1
2015 Jemaà M, Manic G, Lledo G, Lissa D, Reynes C, Morin N, Chibon F, Sistigu A, Castedo M, Vitale I, Kroemer G, Abrieu A. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition. Oncotarget. PMID 26637805 DOI: 10.18632/oncotarget.6432  0.96
2015 Garg AD, Galluzzi L, Apetoh L, Baert T, Birge RB, Bravo-San Pedro JM, Breckpot K, Brough D, Chaurio R, Cirone M, Coosemans A, Coulie PG, De Ruysscher D, Dini L, de Witte P, ... ... Kroemer G, et al. Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death. Frontiers in Immunology. 6: 588. PMID 26635802 DOI: 10.3389/fimmu.2015.00588  0.64
2015 Galluzzi L, Kroemer G. Defective autophagy gets to the brain. Oncotarget. 6: 39396-7. PMID 26575951 DOI: 10.18632/oncotarget.6318  1
2015 Forveille S, Zhou H, Sauvat A, Bezu L, Müller K, Liu P, Zitvogel L, Pierron G, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 triggers necrotic cell death. Cell Cycle (Georgetown, Tex.). 14: 3506-12. PMID 26566869 DOI: 10.1080/15384101.2015.1093710  0.96
2015 Vétizou M, Pitt JM, Daillère R, Lepage P, Waldschmitt N, Flament C, Rusakiewicz S, Routy B, Roberti MP, Duong CP, Poirier-Colame V, Roux A, Becharef S, Formenti S, Golden E, ... ... Kroemer G, et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science (New York, N.Y.). PMID 26541610 DOI: 10.1126/science.aad1329  0.32
2015 Galluzzi L, Pietrocola F, Kroemer G. Molecular Regulation of Circadian Rhythms by Polyamines. Cell Metabolism. 22: 757-8. PMID 26536485 DOI: 10.1016/j.cmet.2015.10.007  1
2015 Bloy N, Sauvat A, Chaba K, Buqué A, Humeau J, Bravo-San Pedro JM, Bui J, Kepp O, Kroemer G, Senovilla L. Morphometric analysis of immunoselection against hyperploid cancer cells. Oncotarget. 6: 41204-15. PMID 26517677 DOI: 10.18632/oncotarget.5400  0.96
2015 Ladoire S, Penault-Llorca F, Senovilla L, Dalban C, Enot D, Locher C, Prada N, Poirier-Colame V, Chaba K, Arnould L, Ghiringhelli F, Fumoleau P, Spielmann M, Delaloge S, Poillot ML, ... ... Kroemer G, et al. Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancer. Autophagy. 11: 1878-90. PMID 26506894 DOI: 10.1080/15548627.2015.1082022  0.88
2015 Seah S, Low IC, Hirpara JL, Sachaphibulkij K, Kroemer G, Brenner C, Pervaiz S. Activation of surrogate death receptor signaling triggers peroxynitrite-dependent execution of cisplatin-resistant cancer cells. Cell Death & Disease. 6: e1926. PMID 26492363 DOI: 10.1038/cddis.2015.299  0.52
2015 Aranda F, Buqué A, Bloy N, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for oncological indications. Oncoimmunology. 4: e1046673. PMID 26451319 DOI: 10.1080/2162402X.2015.1046673  1
2015 Semeraro M, Rusakiewicz S, Zitvogel L, Kroemer G. Natural killer cell mediated immunosurveillance of pediatric neuroblastoma. Oncoimmunology. 4: e1042202. PMID 26451315 DOI: 10.1080/2162402X.2015.1042202  0.88
2015 Kroemer G, Senovilla L, Galluzzi L, André F, Zitvogel L. Natural and therapy-induced immunosurveillance in breast cancer. Nature Medicine. 21: 1128-38. PMID 26444637 DOI: 10.1038/nm.3944  1
2015 Vacchelli E, Sistigu A, Yamazaki T, Vitale I, Zitvogel L, Kroemer G. Autocrine signaling of type 1 interferons in successful anticancer chemotherapy. Oncoimmunology. 4: e988042. PMID 26405588 DOI: 10.4161/2162402X.2014.988042  0.64
2015 Grosjean-Raillard J, Adès L, Boehrer S, Tailler M, Fabre C, Braun T, De Botton S, Israel A, Fenaux P, Kroemer G. Erratum to: Flt3 receptor inhibition reduces constitutive NFκB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia. Apoptosis : An International Journal On Programmed Cell Death. 20: 1666-7. PMID 26400497 DOI: 10.1007/s10495-015-1154-9  0.68
2015 Zhou H, Forveille S, Sauvat A, Sica V, Izzo V, Durand S, Müller K, Liu P, Zitvogel L, Rekdal Ø, Kepp O, Kroemer G. The oncolytic peptide LTX-315 kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization. Oncotarget. PMID 26378049 DOI: 10.18632/oncotarget.5613  0.48
2015 Piacentini M, Kroemer G. Dying to survive - apoptosis, necroptosis, autophagy as supreme experiments of nature. The International Journal of Developmental Biology. 59: 5-9. PMID 26374520 DOI: 10.1387/ijdb.150167mp  0.64
2015 Vacchelli E, Semeraro M, Enot DP, Chaba K, Poirier Colame V, Dartigues P, Perier A, Villa I, Rusakiewicz S, Gronnier C, Goéré D, Mariette C, Zitvogel L, Kroemer G. Negative prognostic impact of regulatory T cell infiltration in surgically resected esophageal cancer post-radiochemotherapy. Oncotarget. 6: 20840-50. PMID 26369701 DOI: 10.18632/oncotarget.4428  0.92
2015 Zitvogel L, Kroemer G. Subversion of anticancer immunosurveillance by radiotherapy. Nature Immunology. 16: 1005-7. PMID 26343538 DOI: 10.1038/ni.3236  0.88
2015 Fucikova J, Moserova I, Urbanova L, Bezu L, Kepp O, Cremer I, Salek C, Strnad P, Kroemer G, Galluzzi L, Spisek R. Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology. 6: 402. PMID 26300886 DOI: 10.3389/fimmu.2015.00402  1
2015 Sica V, Galluzzi L, Bravo-San Pedro JM, Izzo V, Maiuri MC, Kroemer G. Organelle-Specific Initiation of Autophagy. Molecular Cell. 59: 522-39. PMID 26295960 DOI: 10.1016/j.molcel.2015.07.021  1
2015 Nardacci R, Perfettini JL, Grieco L, Thieffry D, Kroemer G, Piacentini M. Syncytial apoptosis signaling network induced by the HIV-1 envelope glycoprotein complex: an overview. Cell Death & Disease. 6: e1846. PMID 26247731 DOI: 10.1038/cddis.2015.204  0.64
2015 Gentili M, Kowal J, Tkach M, Satoh T, Lahaye X, Conrad C, Boyron M, Lombard B, Durand S, Kroemer G, Loew D, Dalod M, Théry C, Manel N. Transmission of innate immune signaling by packaging of cGAMP in viral particles. Science (New York, N.Y.). PMID 26229115 DOI: 10.1126/science.aab3628  0.64
2015 Zitvogel L, Kroemer G. CANCER. A p53-regulated immune checkpoint relevant to cancer. Science (New York, N.Y.). 349: 476-7. PMID 26228128 DOI: 10.1126/science.aac8475  0.88
2015 Yang H, Yamazaki T, Pietrocola F, Zhou H, Zitvogel L, Ma Y, Kroemer G. STAT3 inhibition enhances the therapeutic efficacy of immunogenic chemotherapy by stimulating type 1 interferon production by cancer cells. Cancer Research. PMID 26208907 DOI: 10.1158/0008-5472.CAN-15-1122  0.64
2015 Modjtahedi N, Hangen E, Gonin P, Kroemer G. Metabolic epistasis among apoptosis-inducing factor and the mitochondrial import factor CHCHD4. Cell Cycle (Georgetown, Tex.). 14: 2743-7. PMID 26178476 DOI: 10.1080/15384101.2015.1068477  0.64
2015 Kroemer G, Galluzzi L. Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma. Oncoimmunology. 4: e1008853. PMID 26155425 DOI: 10.1080/2162402X.2015.1008853  1
2015 Bloy N, Buqué A, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Naked and vectored DNA-based anticancer vaccines. Oncoimmunology. 4: e1026531. PMID 26155408 DOI: 10.1080/2162402X.2015.1026531  1
2015 Stoll G, Zitvogel L, Kroemer G. Immune infiltrate in cancer. Aging. 7: 358-9. PMID 26143478 DOI: 10.18632/aging.100770  0.88
2015 Kroemer G, Galluzzi L, Zitvogel L, Fridman WH. Colorectal cancer: the first neoplasia found to be under immunosurveillance and the last one to respond to immunotherapy? Oncoimmunology. 4: e1058597. PMID 26140250 DOI: 10.1080/2162402X.2015.1058597  1
2015 Kroemer G, Galluzzi L. Combinatorial immunotherapy with checkpoint blockers solves the problem of metastatic melanoma-An exclamation sign with a question mark. Oncoimmunology. 4: e1058037. PMID 26140249 DOI: 10.1080/2162402X.2015.1058037  1
2015 Pol J, Bloy N, Buqué A, Eggermont A, Cremer I, Sautès-Fridman C, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide-based anticancer vaccines. Oncoimmunology. 4: e974411. PMID 26137405 DOI: 10.4161/2162402X.2014.974411  1
2015 Pol J, Vacchelli E, Aranda F, Castoldi F, Eggermont A, Cremer I, Sautès-Fridman C, Fucikova J, Galon J, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy. Oncoimmunology. 4: e1008866. PMID 26137404 DOI: 10.1080/2162402X.2015.1008866  1
2015 Buqué A, Bloy N, Aranda F, Castoldi F, Eggermont A, Cremer I, Fridman WH, Fucikova J, Galon J, Marabelle A, Spisek R, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunomodulatory monoclonal antibodies for oncological indications. Oncoimmunology. 4: e1008814. PMID 26137403 DOI: 10.1080/2162402X.2015.1008814  1
2015 Enot DP, Niso-Santano M, Durand S, Chery A, Pietrocola F, Vacchelli E, Madeo F, Galluzzi L, Kroemer G. Metabolomic analyses reveal that anti-aging metabolites are depleted by palmitate but increased by oleate in vivo. Cell Cycle (Georgetown, Tex.). 14: 2399-407. PMID 26098646 DOI: 10.1080/15384101.2015.1064206  0.48
2015 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Necrosis: Linking the Inflammasome to Inflammation. Cell Reports. 11: 1501-2. PMID 26082972 DOI: 10.1016/j.celrep.2015.05.041  1
2015 Bezu L, Gomes-da-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Corrigendum: "Combinatorial Strategies for the Induction of Immunogenic Cell Death". Frontiers in Immunology. 6: 275. PMID 26082782 DOI: 10.3389/fimmu.2015.00275  1
2015 Stoll G, Bindea G, Mlecnik B, Galon J, Zitvogel L, Kroemer G. Meta-analysis of organ-specific differences in the structure of the immune infiltrate in major malignancies. Oncotarget. 6: 11894-909. PMID 26059437 DOI: 10.18632/oncotarget.4180  0.88
2015 Maiuri L, De Stefano D, Raia V, Kroemer G. The holy grail of cystic fibrosis research: pharmacological repair of the F508del-CFTR mutation. Annals of Translational Medicine. 3: S24. PMID 26046070 DOI: 10.3978/j.issn.2305-5839.2015.02.32  0.32
2015 Pietrocola F, Galluzzi L, Bravo-San Pedro JM, Madeo F, Kroemer G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metabolism. 21: 805-21. PMID 26039447 DOI: 10.1016/j.cmet.2015.05.014  1
2015 Bouvier M, Chneiweiss H, Jordan B, Lagrue G, Ménard J, Teillaud JL, Kroemer G, Moulin AM, Flahault A, Lafanechère L, Maréchal É, Guillemot JC, Gaille M. The 2010 years | Les années 2010 MéDecine Sciences : M/S. 31: 91-111. PMID 26038813 DOI: 10.1051/medsci/201531s1006  0.64
2015 Peschanski M, Bergeron M, Boué A, Coppens Y, Changeux JP, Corvol P, Lazar P, Kahn A, Bichet DG, Friedlander G, Epelbaum J, Kroemer G, Chneiweiss H, Munnich A, Bouvier M, et al. [In Process Citation]. MéDecine Sciences : M/S. 31: 47-90. PMID 26038812 DOI: 10.1051/medsci/201531s1005  0.64
2015 Zitvogel L, Galluzzi L, Kepp O, Smyth MJ, Kroemer G. Type I interferons in anticancer immunity. Nature Reviews. Immunology. 15: 405-14. PMID 26027717 DOI: 10.1038/nri3845  1
2015 Hangen E, Féraud O, Lachkar S, Mou H, Doti N, Fimia GM, Lam NV, Zhu C, Godin I, Muller K, Chatzi A, Nuebel E, Ciccosanti F, Flamant S, Bénit P, ... ... Kroemer G, et al. Interaction between AIF and CHCHD4 Regulates Respiratory Chain Biogenesis. Molecular Cell. 58: 1001-14. PMID 26004228 DOI: 10.1016/j.molcel.2015.04.020  0.64
2015 Bezu L, Gomes-de-Silva LC, Dewitte H, Breckpot K, Fucikova J, Spisek R, Galluzzi L, Kepp O, Kroemer G. Combinatorial strategies for the induction of immunogenic cell death. Frontiers in Immunology. 6: 187. PMID 25964783 DOI: 10.3389/fimmu.2015.00187  1
2015 Vacchelli E, Pol J, Bloy N, Eggermont A, Cremer I, Fridman WH, Galon J, Marabelle A, Kohrt H, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Tumor-targeting monoclonal antibodies for oncological indications. Oncoimmunology. 4: e985940. PMID 25949870 DOI: 10.4161/2162402X.2014.985940  1
2015 Zitvogel L, Kroemer G. Cancer: Antibodies regulate antitumour immunity. Nature. 521: 35-7. PMID 25924066 DOI: 10.1038/nature14388  0.88
2015 Semeraro M, Rusakiewicz S, Minard-Colin V, Delahaye NF, Enot D, Vély F, Marabelle A, Papoular B, Piperoglou C, Ponzoni M, Perri P, Tchirkov A, Matta J, Lapierre V, Shekarian T, ... ... Kroemer G, et al. Clinical impact of the NKp30/B7-H6 axis in high-risk neuroblastoma patients. Science Translational Medicine. 7: 283ra55. PMID 25877893 DOI: 10.1126/scitranslmed.aaa2327  0.88
2015 Sauvat A, Wang Y, Segura F, Spaggiari S, Müller K, Zhou H, Galluzzi L, Kepp O, Kroemer G. Quantification of cellular viability by automated microscopy and flow cytometry. Oncotarget. 6: 9467-75. PMID 25816366  1
2015 Braun RJ, Sommer C, Leibiger C, Gentier RJ, Dumit VI, Paduch K, Eisenberg T, Habernig L, Trausinger G, Magnes C, Pieber T, Sinner F, Dengjel J, van Leeuwen FW, Kroemer G, et al. Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin. Cell Reports. PMID 25753421 DOI: 10.1016/j.celrep.2015.02.009  0.88
2015 Kepp O, Semeraro M, Bravo-San Pedro JM, Bloy N, Buqué A, Huang X, Zhou H, Senovilla L, Kroemer G, Galluzzi L. eIF2α phosphorylation as a biomarker of immunogenic cell death. Seminars in Cancer Biology. PMID 25749194 DOI: 10.1016/j.semcancer.2015.02.004  1
2015 Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, ... ... Kroemer G, et al. Erratum: anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Research. 25: 399-400. PMID 25732764 DOI: 10.1038/cr.2015.28  0.64
2015 Pedro JM, Wei Y, Sica V, Maiuri MC, Zou Z, Kroemer G, Levine B. BAX and BAK1 are dispensable for ABT-737-induced dissociation of the BCL2-BECN1 complex and autophagy. Autophagy. 11: 452-9. PMID 25715028 DOI: 10.1080/15548627.2015.1017191  0.64
2015 Niso-Santano M, Bravo-San Pedro JM, Maiuri MC, Tavernarakis N, Cecconi F, Madeo F, Codogno P, Galluzzi L, Kroemer G. Novel inducers of BECN1-independent autophagy: cis-unsaturated fatty acids. Autophagy. 11: 575-7. PMID 25714112 DOI: 10.1080/15548627.2015.1017222  0.64
2015 Galluzzi L, Pietrocola F, Bravo-San Pedro JM, Amaravadi RK, Baehrecke EH, Cecconi F, Codogno P, Debnath J, Gewirtz DA, Karantza V, Kimmelman A, Kumar S, Levine B, Maiuri MC, Martin SJ, ... ... Kroemer G, et al. Autophagy in malignant transformation and cancer progression. The Embo Journal. 34: 856-80. PMID 25712477 DOI: 10.15252/embj.201490784  0.64
2015 Madeo F, Zimmermann A, Maiuri MC, Kroemer G. Essential role for autophagy in life span extension. The Journal of Clinical Investigation. 125: 85-93. PMID 25654554 DOI: 10.1172/JCI73946  0.96
2015 Zitvogel L, Galluzzi L, Viaud S, Vétizou M, Daillère R, Merad M, Kroemer G. Cancer and the gut microbiota: an unexpected link. Science Translational Medicine. 7: 271ps1. PMID 25609166 DOI: 10.1126/scitranslmed.3010473  1
2015 Niso-Santano M, Malik SA, Pietrocola F, Bravo-San Pedro JM, Mariño G, Cianfanelli V, Ben-Younès A, Troncoso R, Markaki M, Sica V, Izzo V, Chaba K, Bauvy C, Dupont N, Kepp O, ... ... Kroemer G, et al. Unsaturated fatty acids induce non-canonical autophagy. The Embo Journal. 34: 1025-41. PMID 25586377 DOI: 10.15252/embj.201489363  0.4
2015 Hannani D, Vétizou M, Enot D, Rusakiewicz S, Chaput N, Klatzmann D, Desbois M, Jacquelot N, Vimond N, Chouaib S, Mateus C, Allison JP, Ribas A, Wolchok JD, Yuan J, ... ... Kroemer G, et al. Anticancer immunotherapy by CTLA-4 blockade: obligatory contribution of IL-2 receptors and negative prognostic impact of soluble CD25. Cell Research. 25: 208-24. PMID 25582080 DOI: 10.1038/cr.2015.3  0.88
2015 Rockenfeller P, Koska M, Pietrocola F, Minois N, Knittelfelder O, Sica V, Franz J, Carmona-Gutierrez D, Kroemer G, Madeo F. Phosphatidylethanolamine positively regulates autophagy and longevity. Cell Death and Differentiation. 22: 499-508. PMID 25571976 DOI: 10.1038/cdd.2014.219  0.64
2015 Maiuri MC, Kroemer G. Essential role for oxidative phosphorylation in cancer progression. Cell Metabolism. 21: 11-2. PMID 25565201 DOI: 10.1016/j.cmet.2014.12.013  0.96
2015 Pietrocola F, Lachkar S, Enot DP, Niso-Santano M, Bravo-San Pedro JM, Sica V, Izzo V, Maiuri MC, Madeo F, Mariño G, Kroemer G. Spermidine induces autophagy by inhibiting the acetyltransferase EP300. Cell Death and Differentiation. 22: 509-16. PMID 25526088 DOI: 10.1038/cdd.2014.215  1
2015 Braun R, Sommer C, Leibiger C, Gentier RG, Dumit V, Paduch K, Eisenberg T, Habernig L, Trausinger G, Magnes C, Pieber T, Sinner F, Dengjel J, vanLeeuwen F, Kroemer G, et al. Accumulation of basic amino acids at mitochondria dictates the cytotoxicity of aberrant ubiquitin Cell Reports. 10: 1557-1571. DOI: 10.1016/j.celrep.2015.02.009  0.32
2014 Ruckenstuhl C, Netzberger C, Entfellner I, Carmona-Gutierrez D, Kickenweiz T, Stekovic S, Gleixner C, Schmid C, Klug L, Hajnal I, Sorgo AG, Eisenberg T, Büttner S, Marin O G, Koziel R, ... ... Kroemer G, et al. Autophagy extends lifespan via vacuolar acidification. Microbial Cell (Graz, Austria). 1: 160-162. PMID 28357240 DOI: 10.15698/mic2014.05.147  0.88
2014 Zimmermann A, Bauer MA, Kroemer G, Madeo F, Carmona-Gutierrez D. When less is more: hormesis against stress and disease. Microbial Cell (Graz, Austria). 1: 150-153. PMID 28357237 DOI: 10.15698/mic2014.05.148  0.88
2014 Carmona-Gutierrez D, Kroemer G, Madeo F. One cell, one love: a journal for microbial research. Microbial Cell (Graz, Austria). 1: 1-5. PMID 28357205 DOI: 10.15698/mic2014.01.118  0.88
2014 Galluzzi L, Kroemer G. Molecular and Cellular Oncology: A new journal for a changing field. Molecular & Cellular Oncology. 1: e977612. PMID 27308338 DOI: 10.4161/23723556.2014.977612  1
2014 Manic G, Obrist F, Kroemer G, Vitale I, Galluzzi L. Chloroquine and hydroxychloroquine for cancer therapy. Molecular & Cellular Oncology. 1: e29911. PMID 27308318 DOI: 10.4161/mco.29911  1
2014 Galluzzi L, Kroemer G. Molecular and Cellular Oncology: A new journal for a changing field. Molecular & Cellular Oncology. 1: e29052. PMID 27308308 DOI: 10.4161/mco.29052  1
2014 Aranda F, Bloy N, Galluzzi L, Kroemer G, Senovilla L. Vitamin B6 improves the immunogenicity of cisplatin-induced cell death. Oncoimmunology. 3: e955685. PMID 25941619 DOI: 10.4161/21624011.2014.955685  1
2014 Bloy N, Pol J, Manic G, Vitale I, Eggermont A, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Radioimmunotherapy for oncological indications. Oncoimmunology. 3: e954929. PMID 25941606 DOI: 10.4161/21624011.2014.954929  1
2014 Galluzzi L, Kroemer G, Eggermont A. Novel immune checkpoint blocker approved for the treatment of advanced melanoma. Oncoimmunology. 3: e967147. PMID 25941597 DOI: 10.4161/21624011.2014.967147  1
2014 Bloy N, Pol J, Aranda F, Eggermont A, Cremer I, Fridman WH, Fučíková J, Galon J, Tartour E, Spisek R, Dhodapkar MV, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based anticancer therapy. Oncoimmunology. 3: e963424. PMID 25941593 DOI: 10.4161/21624011.2014.963424  1
2014 Vacchelli E, Aranda F, Eggermont A, Sautès-Fridman C, Tartour E, Kennedy EP, Platten M, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology. 3: e957994. PMID 25941578 DOI: 10.4161/21624011.2014.957994  0.64
2014 Michaud M, Xie X, Bravo-San Pedro JM, Zitvogel L, White E, Kroemer G. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology. 3: e944047. PMID 25610726 DOI: 10.4161/21624011.2014.944047  0.92
2014 Galluzzi L, Vacchelli E, Bravo-San Pedro JM, Buqué A, Senovilla L, Baracco EE, Bloy N, Castoldi F, Abastado JP, Agostinis P, Apte RN, Aranda F, Ayyoub M, Beckhove P, Blay JY, ... ... Kroemer G, et al. Classification of current anticancer immunotherapies. Oncotarget. 5: 12472-508. PMID 25537519 DOI: 10.18632/oncotarget.2998  1
2014 Zitvogel L, Kroemer G. CD103+ dendritic cells producing interleukin-12 in anticancer immunosurveillance. Cancer Cell. 26: 591-3. PMID 25517740 DOI: 10.1016/j.ccell.2014.10.008  0.88
2014 Bonora M, Bravo-San Pedro JM, Kroemer G, Galluzzi L, Pinton P. Novel insights into the mitochondrial permeability transition. Cell Cycle (Georgetown, Tex.). 13: 2666-70. PMID 25486353 DOI: 10.4161/15384101.2014.949082  1
2014 Mariño G, Pietrocola F, Madeo F, Kroemer G. Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers. Autophagy. 10: 1879-82. PMID 25484097 DOI: 10.4161/auto.36413  0.96
2014 Büttner S, Broeskamp F, Sommer C, Markaki M, Habernig L, Alavian-Ghavanini A, Carmona-Gutierrez D, Eisenberg T, Michael E, Kroemer G, Tavernarakis N, Sigrist SJ, Madeo F. Spermidine protects against α-synuclein neurotoxicity. Cell Cycle (Georgetown, Tex.). 13: 3903-8. PMID 25483063 DOI: 10.4161/15384101.2014.973309  0.32
2014 Galluzzi L, Pietrocola F, Levine B, Kroemer G. Metabolic control of autophagy. Cell. 159: 1263-76. PMID 25480292 DOI: 10.1016/j.cell.2014.11.006  0.64
2014 Thepot S, Boehrer S, Seegers V, Prebet T, Beyne-Rauzy O, Wattel E, Delaunay J, Raffoux E, Hunault M, Jourdan E, Chermat F, Sebert M, Kroemer G, Fenaux P, Adès L, et al. A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure. Leukemia Research. 38: 1430-4. PMID 25449687 DOI: 10.1016/j.leukres.2014.09.014  0.6
2014 De Stefano D, Villella VR, Esposito S, Tosco A, Sepe A, De Gregorio F, Salvadori L, Grassia R, Leone CA, De Rosa G, Maiuri MC, Pettoello-Mantovani M, Guido S, Bossi A, Zolin A, ... ... Kroemer G, et al. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation. Autophagy. 10: 2053-74. PMID 25350163 DOI: 10.4161/15548627.2014.973737  0.96
2014 Sistigu A, Yamazaki T, Vacchelli E, Chaba K, Enot DP, Adam J, Vitale I, Goubar A, Baracco EE, Remédios C, Fend L, Hannani D, Aymeric L, Ma Y, Niso-Santano M, ... ... Kroemer G, et al. Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. Nature Medicine. 20: 1301-9. PMID 25344738 DOI: 10.1038/nm.3708  0.32
2014 Kroemer G, Perfettini JL. Entosis, a key player in cancer cell competition. Cell Research. 24: 1280-1. PMID 25342563 DOI: 10.1038/cr.2014.133  0.76
2014 Zitvogel L, Kroemer G. Cytokines reinstate NK cell-mediated cancer immunosurveillance. The Journal of Clinical Investigation. 124: 4687-9. PMID 25329691 DOI: 10.1172/JCI78531  0.88
2014 Zitvogel L, Kroemer G. Targeting foxp1 for reinstating anticancer immunosurveillance. Immunity. 41: 345-7. PMID 25238089 DOI: 10.1016/j.immuni.2014.09.001  0.88
2014 Green DR, Galluzzi L, Kroemer G. Cell biology. Metabolic control of cell death. Science (New York, N.Y.). 345: 1250256. PMID 25237106 DOI: 10.1126/science.1250256  1
2014 Loriot Y, Mordant P, Dugue D, Geneste O, Gombos A, Opolon P, Guegan J, Perfettini JL, Pierre A, Berthier LK, Kroemer G, Soria JC, Depil S, Deutsch E. Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancer. Cell Death & Disease. 5: e1423. PMID 25232677 DOI: 10.1038/cddis.2014.365  0.76
2014 Madeo F, Pietrocola F, Eisenberg T, Kroemer G. Caloric restriction mimetics: towards a molecular definition. Nature Reviews. Drug Discovery. 13: 727-40. PMID 25212602 DOI: 10.1038/nrd4391  0.96
2014 Michels J, Obrist F, Castedo M, Vitale I, Kroemer G. PARP and other prospective targets for poisoning cancer cell metabolism. Biochemical Pharmacology. 92: 164-71. PMID 25199458 DOI: 10.1016/j.bcp.2014.08.026  0.96
2014 Kepp O, Senovilla L, Kroemer G. Immunogenic cell death inducers as anticancer agents. Oncotarget. 5: 5190-1. PMID 25114034 DOI: 10.18632/oncotarget.2266  0.96
2014 Michels J, Obrist F, Vitale I, Lissa D, Garcia P, Behnam-Motlagh P, Kohno K, Wu GS, Brenner C, Castedo M, Kroemer G. MCL-1 dependency of cisplatin-resistant cancer cells. Biochemical Pharmacology. 92: 55-61. PMID 25107702 DOI: 10.1016/j.bcp.2014.07.029  0.64
2014 Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Cremer I, Erbs P, Limacher JM, Preville X, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch:: Oncolytic viruses for cancer therapy. Oncoimmunology. 3: e28694. PMID 25097804 DOI: 10.4161/onci.28694  1
2014 Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Henrik Ter Meulen J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists in oncological indications. Oncoimmunology. 3: e29179. PMID 25083332 DOI: 10.4161/onci.29179  1
2014 Vacchelli E, Aranda F, Obrist F, Eggermont A, Galon J, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Immunostimulatory cytokines in cancer therapy. Oncoimmunology. 3: e29030. PMID 25083328 DOI: 10.4161/onci.29030  1
2014 Galluzzi L, Bravo-San Pedro JM, Kroemer G. Organelle-specific initiation of cell death. Nature Cell Biology. 16: 728-36. PMID 25082195 DOI: 10.1038/ncb3005  1
2014 Sukkurwala AQ, Adjemian S, Senovilla L, Michaud M, Spaggiari S, Vacchelli E, Baracco EE, Galluzzi L, Zitvogel L, Kepp O, Kroemer G. Screening of novel immunogenic cell death inducers within the NCI Mechanistic Diversity Set. Oncoimmunology. 3: e28473. PMID 25050214 DOI: 10.4161/onci.28473  1
2014 Aranda F, Vacchelli E, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 3: e28344. PMID 25050207 DOI: 10.4161/onci.28344  1
2014 Michaud M, Sukkurwala AQ, Di Sano F, Zitvogel L, Kepp O, Kroemer G. Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress. Oncoimmunology. 3: e28276. PMID 25050202 DOI: 10.4161/onci.28276  0.96
2014 Senovilla L, Aranda F, Galluzzi L, Kroemer G. Impact of myeloid cells on the efficacy of anticancer chemotherapy. Current Opinion in Immunology. 30: 24-31. PMID 24950501 DOI: 10.1016/j.coi.2014.05.009  1
2014 Galluzzi L, Kroemer G. Preface: oncometabolism: a new field of research with profound therapeutic implications. Methods in Enzymology. 543: xv-xix. PMID 24924141 DOI: 10.1016/B978-0-12-801329-8.10000-5  1
2014 Scoazec M, Durand S, Chery A, Galluzzi L, Kroemer G. Metabolomic profiling of cultured cancer cells. Methods in Enzymology. 543: 165-78. PMID 24924132 DOI: 10.1016/B978-0-12-801329-8.00008-8  0.64
2014 Nassif M, Valenzuela V, Rojas-Rivera D, Vidal R, Matus S, Castillo K, Fuentealba Y, Kroemer G, Levine B, Hetz C. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis. Autophagy. 10: 1256-71. PMID 24905722 DOI: 10.4161/auto.28784  0.48
2014 Schroeder S, Pendl T, Zimmermann A, Eisenberg T, Carmona-Gutierrez D, Ruckenstuhl C, Mariño G, Pietrocola F, Harger A, Magnes C, Sinner F, Pieber TR, Dengjel J, Sigrist SJ, Kroemer G, et al. Acetyl-coenzyme A: a metabolic master regulator of autophagy and longevity. Autophagy. 10: 1335-7. PMID 24904996 DOI: 10.4161/auto.28919  0.32
2014 Eisenberg T, Schroeder S, Büttner S, Carmona-Gutierrez D, Pendl T, Andryushkova A, Mariño G, Pietrocola F, Harger A, Zimmermann A, Magnes C, Sinner F, Sedej S, Pieber TR, Dengjel J, ... ... Kroemer G, et al. A histone point mutation that switches on autophagy. Autophagy. 10: 1143-5. PMID 24879160 DOI: 10.4161/auto.28767  0.32
2014 Galluzzi L, Vitale I, Michels J, Brenner C, Szabadkai G, Harel-Bellan A, Castedo M, Kroemer G. Systems biology of cisplatin resistance: past, present and future. Cell Death & Disease. 5: e1257. PMID 24874729 DOI: 10.1038/cddis.2013.428  0.64
2014 Galluzzi L, Kroemer G. Preface: oncometabolism: a new field of research with profound therapeutic implications. Methods in Enzymology. 542: xix-xxiii. PMID 24862280 DOI: 10.1016/B978-0-12-416618-9.10000-7  1
2014 Pol J, Bloy N, Obrist F, Eggermont A, Galon J, Hervé Fridman W, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: DNA vaccines for cancer therapy. Oncoimmunology. 3: e28185. PMID 24800178 DOI: 10.4161/onci.28185  1
2014 Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Cremer I, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Chemotherapy with immunogenic cell death inducers. Oncoimmunology. 3: e27878. PMID 24800173 DOI: 10.4161/onci.27878  1
2014 Ma Y, Adjemian S, Galluzzi L, Zitvogel L, Kroemer G. Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy. Oncoimmunology. 3: e27663. PMID 24800170 DOI: 10.4161/onci.27663  1
2014 Pietrocola F, Malik SA, Mariño G, Vacchelli E, Senovilla L, Chaba K, Niso-Santano M, Maiuri MC, Madeo F, Kroemer G. Coffee induces autophagy in vivo. Cell Cycle (Georgetown, Tex.). 13: 1987-94. PMID 24769862 DOI: 10.4161/cc.28929  0.96
2014 Aranda F, Vacchelli E, Eggermont A, Galon J, Fridman WH, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27297. PMID 24701370 DOI: 10.4161/onci.27297  1
2014 Mariño G, Pietrocola F, Kong Y, Eisenberg T, Hill JA, Madeo F, Kroemer G. Dimethyl α-ketoglutarate inhibits maladaptive autophagy in pressure overload-induced cardiomyopathy. Autophagy. 10: 930-2. PMID 24675140 DOI: 10.4161/auto.28235  0.96
2014 Eisenberg T, Schroeder S, Andryushkova A, Pendl T, Küttner V, Bhukel A, Mariño G, Pietrocola F, Harger A, Zimmermann A, Moustafa T, Sprenger A, Jany E, Büttner S, Carmona-Gutierrez D, ... ... Kroemer G, et al. Nucleocytosolic depletion of the energy metabolite acetyl-coenzyme a stimulates autophagy and prolongs lifespan. Cell Metabolism. 19: 431-44. PMID 24606900 DOI: 10.1016/j.cmet.2014.02.010  0.32
2014 Vacchelli E, Aranda F, Eggermont A, Galon J, Sautès-Fridman C, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapy. Oncoimmunology. 3: e27048. PMID 24605265 DOI: 10.4161/onci.27048  1
2014 Galluzzi L, Kepp O, Krautwald S, Kroemer G, Linkermann A. Molecular mechanisms of regulated necrosis. Seminars in Cell & Developmental Biology. 35: 24-32. PMID 24582829 DOI: 10.1016/j.semcdb.2014.02.006  1
2014 Mariño G, Pietrocola F, Eisenberg T, Kong Y, Malik SA, Andryushkova A, Schroeder S, Pendl T, Harger A, Niso-Santano M, Zamzami N, Scoazec M, Durand S, Enot DP, Fernández ÁF, ... ... Kroemer G, et al. Regulation of autophagy by cytosolic acetyl-coenzyme A. Molecular Cell. 53: 710-25. PMID 24560926 DOI: 10.1016/j.molcel.2014.01.016  1
2014 Lissa D, Senovilla L, Rello-Varona S, Vitale I, Michaud M, Pietrocola F, Boilève A, Obrist F, Bordenave C, Garcia P, Michels J, Jemaà M, Kepp O, Castedo M, Kroemer G. Resveratrol and aspirin eliminate tetraploid cells for anticancer chemoprevention. Proceedings of the National Academy of Sciences of the United States of America. 111: 3020-5. PMID 24516128 DOI: 10.1073/pnas.1318440111  0.96
2014 Tufo G, Jones AW, Wang Z, Hamelin J, Tajeddine N, Esposti DD, Martel C, Boursier C, Gallerne C, Migdal C, Lemaire C, Szabadkai G, Lemoine A, Kroemer G, Brenner C. The protein disulfide isomerases PDIA4 and PDIA6 mediate resistance to cisplatin-induced cell death in lung adenocarcinoma. Cell Death and Differentiation. 21: 685-95. PMID 24464223 DOI: 10.1038/cdd.2013.193  0.64
2014 Rao S, Tortola L, Perlot T, Wirnsberger G, Novatchkova M, Nitsch R, Sykacek P, Frank L, Schramek D, Komnenovic V, Sigl V, Aumayr K, Schmauss G, Fellner N, Handschuh S, ... ... Kroemer G, et al. A dual role for autophagy in a murine model of lung cancer. Nature Communications. 5: 3056. PMID 24445999 DOI: 10.1038/ncomms4056  0.64
2014 Galluzzi L, Kepp O, Kroemer G. MLKL regulates necrotic plasma membrane permeabilization. Cell Research. 24: 139-40. PMID 24418759 DOI: 10.1038/cr.2014.8  1
2014 Rao S, Yang H, Penninger JM, Kroemer G. Autophagy in non-small cell lung carcinogenesis: A positive regulator of antitumor immunosurveillance. Autophagy. 10: 529-31. PMID 24413089 DOI: 10.4161/auto.27643  0.64
2014 Mariño G, Niso-Santano M, Baehrecke EH, Kroemer G. Self-consumption: the interplay of autophagy and apoptosis. Nature Reviews. Molecular Cell Biology. 15: 81-94. PMID 24401948 DOI: 10.1038/nrm3735  0.64
2014 Ma Y, Mattarollo SR, Adjemian S, Yang H, Aymeric L, Hannani D, Portela Catani JP, Duret H, Teng MW, Kepp O, Wang Y, Sistigu A, Schultze JL, Stoll G, Galluzzi L, ... ... Kroemer G, et al. CCL2/CCR2-dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy. Cancer Research. 74: 436-45. PMID 24302580 DOI: 10.1158/0008-5472.CAN-13-1265  1
2014 Ko A, Kanehisa A, Martins I, Senovilla L, Chargari C, Dugue D, Mariño G, Kepp O, Michaud M, Perfettini JL, Kroemer G, Deutsch E. Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling. Cell Death and Differentiation. 21: 92-9. PMID 24037090 DOI: 10.1038/cdd.2013.124  0.96
2014 Martins I, Wang Y, Michaud M, Ma Y, Sukkurwala AQ, Shen S, Kepp O, Métivier D, Galluzzi L, Perfettini JL, Zitvogel L, Kroemer G. Molecular mechanisms of ATP secretion during immunogenic cell death. Cell Death and Differentiation. 21: 79-91. PMID 23852373 DOI: 10.1038/cdd.2013.75  1
2014 Sukkurwala AQ, Martins I, Wang Y, Schlemmer F, Ruckenstuhl C, Durchschlag M, Michaud M, Senovilla L, Sistigu A, Ma Y, Vacchelli E, Sulpice E, Gidrol X, Zitvogel L, Madeo F, ... ... Kroemer G, et al. Immunogenic calreticulin exposure occurs through a phylogenetically conserved stress pathway involving the chemokine CXCL8. Cell Death and Differentiation. 21: 59-68. PMID 23787997 DOI: 10.1038/cdd.2013.73  1
2013 Kroemer G, Galluzzi L, Zitvogel L. Immunological effects of chemotherapy in spontaneous breast cancers. Oncoimmunology. 2: e27158. PMID 24498568 DOI: 10.4161/onci.27158  1
2013 Aranda F, Vacchelli E, Eggermont A, Galon J, Sautès-Fridman C, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Peptide vaccines in cancer therapy. Oncoimmunology. 2: e26621. PMID 24498550 DOI: 10.4161/onci.26621  1
2013 Semeraro M, Vacchelli E, Eggermont A, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Lenalidomide-based immunochemotherapy. Oncoimmunology. 2: e26494. PMID 24482747 DOI: 10.4161/onci.26494  1
2013 Kepp O, Galluzzi L, Kroemer G. Immune effectors required for the therapeutic activity of vorinostat. Oncoimmunology. 2: e27157. PMID 24475375 DOI: 10.4161/onci.27157  1
2013 Galluzzi L, Kepp O, Kroemer G. Immunogenic cell death in radiation therapy. Oncoimmunology. 2: e26536. PMID 24404424 DOI: 10.4161/onci.26536  1
2013 Vacchelli E, Vitale I, Tartour E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Anticancer radioimmunotherapy. Oncoimmunology. 2: e25595. PMID 24319634 DOI: 10.4161/onci.25595  1
2013 Vacchelli E, Vitale I, Eggermont A, Fridman WH, Fučíková J, Cremer I, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Dendritic cell-based interventions for cancer therapy. Oncoimmunology. 2: e25771. PMID 24286020 DOI: 10.4161/onci.25771  1
2013 Viaud S, Saccheri F, Mignot G, Yamazaki T, Daillère R, Hannani D, Enot DP, Pfirschke C, Engblom C, Pittet MJ, Schlitzer A, Ginhoux F, Apetoh L, Chachaty E, Woerther PL, ... ... Kroemer G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (New York, N.Y.). 342: 971-6. PMID 24264990 DOI: 10.1126/science.1240537  0.88
2013 Büttner S, Habernig L, Broeskamp F, Ruli D, Vögtle FN, Vlachos M, Macchi F, Küttner V, Carmona-Gutierrez D, Eisenberg T, Ring J, Markaki M, Taskin AA, Benke S, Ruckenstuhl C, ... ... Kroemer G, et al. Endonuclease G mediates α-synuclein cytotoxicity during Parkinson's disease. The Embo Journal. 32: 3041-54. PMID 24129513 DOI: 10.1038/emboj.2013.228  0.48
2013 Galluzzi L, Kepp O, Vander Heiden MG, Kroemer G. Metabolic targets for cancer therapy. Nature Reviews. Drug Discovery. 12: 829-46. PMID 24113830 DOI: 10.1038/nrd4145  1
2013 Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2: e25238. PMID 24083080 DOI: 10.4161/onci.25238  1
2013 Vacchelli E, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Immunostimulatory cytokines. Oncoimmunology. 2: e24850. PMID 24073369 DOI: 10.4161/onci.24850  1
2013 Gini B, Zanca C, Guo D, Matsutani T, Masui K, Ikegami S, Yang H, Nathanson D, Villa GR, Shackelford D, Zhu S, Tanaka K, Babic I, Akhavan D, Lin K, ... ... Kroemer G, et al. The mTOR kinase inhibitors, CC214-1 and CC214-2, preferentially block the growth of EGFRvIII-activated glioblastomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 5722-32. PMID 24030701 DOI: 10.1158/1078-0432.CCR-13-0527  0.64
2013 Galluzzi L, Kroemer G. Common and divergent functions of Beclin 1 and Beclin 2. Cell Research. 23: 1341-2. PMID 24018378 DOI: 10.1038/cr.2013.129  1
2013 Wang Y, Martins I, Ma Y, Kepp O, Galluzzi L, Kroemer G. Autophagy-dependent ATP release from dying cells via lysosomal exocytosis. Autophagy. 9: 1624-5. PMID 23989612 DOI: 10.4161/auto.25873  1
2013 Lainey E, Wolfromm A, Sukkurwala AQ, Micol JB, Fenaux P, Galluzzi L, Kepp O, Kroemer G. EGFR inhibitors exacerbate differentiation and cell cycle arrest induced by retinoic acid and vitamin D3 in acute myeloid leukemia cells. Cell Cycle (Georgetown, Tex.). 12: 2978-91. PMID 23974111 DOI: 10.4161/cc.26016  1
2013 Ma Y, Galluzzi L, Zitvogel L, Kroemer G. Autophagy and cellular immune responses. Immunity. 39: 211-27. PMID 23973220 DOI: 10.1016/j.immuni.2013.07.017  1
2013 Schmitt S, Saathoff F, Meissner L, Schropp EM, Lichtmannegger J, Schulz S, Eberhagen C, Borchard S, Aichler M, Adamski J, Plesnila N, Rothenfusser S, Kroemer G, Zischka H. A semi-automated method for isolating functionally intact mitochondria from cultured cells and tissue biopsies. Analytical Biochemistry. 443: 66-74. PMID 23969012 DOI: 10.1016/j.ab.2013.08.007  0.64
2013 Vakifahmetoglu-Norberg H, Kim M, Xia HG, Iwanicki MP, Ofengeim D, Coloff JL, Pan L, Ince TA, Kroemer G, Brugge JS, Yuan J. Chaperone-mediated autophagy degrades mutant p53. Genes & Development. 27: 1718-30. PMID 23913924 DOI: 10.1101/gad.220897.113  0.64
2013 Spaggiari S, Kepp O, Rello-Varona S, Chaba K, Adjemian S, Pype J, Galluzzi L, Lemaire M, Kroemer G. Antiapoptotic activity of argon and xenon. Cell Cycle (Georgetown, Tex.). 12: 2636-42. PMID 23907115 DOI: 10.4161/cc.25650  1
2013 Ma Y, Yamazaki T, Yang H, Kepp O, Galluzzi L, Zitvogel L, Smyth MJ, Kroemer G. Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy. Oncoimmunology. 2: e24786. PMID 23894723 DOI: 10.4161/onci.24786  1
2013 Vacchelli E, Eggermont A, Sautès-Fridman C, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: Oncolytic viruses for cancer therapy. Oncoimmunology. 2: e24612. PMID 23894720 DOI: 10.4161/onci.24612  1
2013 Ma Y, Adjemian S, Yang H, Catani JP, Hannani D, Martins I, Michaud M, Kepp O, Sukkurwala AQ, Vacchelli E, Galluzzi L, Zitvogel L, Kroemer G. ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy. Oncoimmunology. 2: e24568. PMID 23894718 DOI: 10.4161/onci.24568  1
2013 Senovilla L, Galluzzi L, Zitvogel L, Kroemer G. Immunosurveillance as a regulator of tissue homeostasis. Trends in Immunology. 34: 471-81. PMID 23891238 DOI: 10.1016/j.it.2013.06.005  1
2013 Zitvogel L, Galluzzi L, Smyth MJ, Kroemer G. Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity. 39: 74-88. PMID 23890065 DOI: 10.1016/j.immuni.2013.06.014  1
2013 Kepp O, Menger L, Vacchelli E, Locher C, Adjemian S, Yamazaki T, Martins I, Sukkurwala AQ, Michaud M, Senovilla L, Galluzzi L, Kroemer G, Zitvogel L. Crosstalk between ER stress and immunogenic cell death. Cytokine & Growth Factor Reviews. 24: 311-8. PMID 23787159 DOI: 10.1016/j.cytogfr.2013.05.001  1
2013 Cabrera S, Fernández AF, Mariño G, Aguirre A, Suárez MF, Español Y, Vega JA, Laurà R, Fueyo A, Fernández-García MS, Freije JM, Kroemer G, López-Otín C. ATG4B/autophagin-1 regulates intestinal homeostasis and protects mice from experimental colitis. Autophagy. 9: 1188-200. PMID 23782979 DOI: 10.4161/auto.24797  0.56
2013 Vacchelli E, Eggermont A, Fridman WH, Galon J, Tartour E, Zitvogel L, Kroemer G, Galluzzi L. Trial Watch: Adoptive cell transfer for anticancer immunotherapy. Oncoimmunology. 2: e24238. PMID 23762803 DOI: 10.4161/onci.24238  1
2013 López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell. 153: 1194-217. PMID 23746838 DOI: 10.1016/j.cell.2013.05.039  0.64
2013 Senovilla L, Vacchelli E, Garcia P, Eggermont A, Fridman WH, Galon J, Zitvogel L, Kroemer G, Galluzzi L. Trial watch: DNA vaccines for cancer therapy. Oncoimmunology. 2: e23803. PMID 23734328 DOI: 10.4161/onci.23803  1
2013 Martins I, Kepp O, Menger L, Michaud M, Adjemian S, Sukkurwala AQ, Vacchelli E, Galluzzi L, Kroemer G. Fluorescent biosensors for the detection of HMGB1 release. Methods in Molecular Biology (Clifton, N.J.). 1004: 43-56. PMID 23733568 DOI: 10.1007/978-1-62703-383-1_4  1
Show low-probability matches.